0001213900-17-012034.txt : 20171114 0001213900-17-012034.hdr.sgml : 20171114 20171114144800 ACCESSION NUMBER: 0001213900-17-012034 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 47 CONFORMED PERIOD OF REPORT: 20170930 FILED AS OF DATE: 20171114 DATE AS OF CHANGE: 20171114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: iSign Solutions Inc. CENTRAL INDEX KEY: 0000727634 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 942790442 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-19301 FILM NUMBER: 171200718 BUSINESS ADDRESS: STREET 1: 2025 GATEWAY PLACE STREET 2: SUITE 485 CITY: SAN JOSE STATE: CA ZIP: 95110 BUSINESS PHONE: 6508027888 MAIL ADDRESS: STREET 1: 2025 GATEWAY PLACE STREET 2: SUITE 485 CITY: SAN JOSE STATE: CA ZIP: 95110 FORMER COMPANY: FORMER CONFORMED NAME: COMMUNICATION INTELLIGENCE CORP DATE OF NAME CHANGE: 19951218 10-Q 1 f10q0917_isignsolutions.htm QUARTERLY REPORT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: September 30, 2017

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 000-19301

iSign Solutions Inc.

(Exact name of registrant as specified in its charter)

Delaware		94-2790442
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification No.)

2025 Gateway Place, Suite 485, San Jose CA 95110

(Address of principal executive offices) (Zip Code)

(650) 802-7888

Registrant's telephone number, including area code

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

☐

large accelerated filer

☐

accelerated filer

☐

non-accelerated filer

☒

Smaller reporting Company

Indicate by check mark whether the registrant is a shell company (as defined in Section 12b-2 of the exchange Act)

Yes ☐ No ☒

Number of shares outstanding of the issuer's Common Stock as of November 14, 2017: 5,761,980.

INDEX

		Page No.
PART I. FINANCIAL INFORMATION

Item 1.	Financial Statements
	Condensed Consolidated Balance Sheets at September 30, 2017 (unaudited) and December 31, 2016	3
	Condensed Consolidated Statements of Operations for the Three- and Nine-Month Periods Ended September 30, 2017 and 2016 (unaudited)	4
	Condensed Consolidated Statements of Cash Flows for the Nine-Month Periods Ended September 30, 2017 and 2016 (unaudited)	5
	Notes to Unaudited Condensed Consolidated Financial Statements	7
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	13
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	18
Item 4.	Controls and Procedures	18

PART II. OTHER INFORMATION

Item 1.	Legal Proceedings	18
Item 1A.	Risk Factors	19
Item 2.	Unregistered Sale of Securities and Use of Proceeds	19
Item 3.	Defaults Upon Senior Securities	19
Item 4.	Mine Safety Disclosures	19
Item 5.	Other Information	19
Item 6.	Exhibits
(a) Exhibits		19
Signatures		23

PART I–FINANCIAL INFORMATION

Item 1. Financial Statements

iSign Solutions Inc.

Condensed Consolidated Balance Sheets

(In thousands)

	September 30,			December 31,
	2017			2016
Assets	(Unaudited)
Current assets:
Cash and cash equivalents	$	164		$	389
Accounts receivable, net of allowance of $0 at September 30, 2017 and $63 at December 31, 2016, respectively		83			137
Prepaid expenses and other current assets		30			56
Total current assets		277			582
Property and equipment, net		12			20
Intangible assets, net		27			269
Other assets		17			17
Total assets	$	333		$	888

Liabilities and Deficit
Current liabilities:
Accounts payable	$	1,295		$	1,368
Accrued compensation		200			257
Other accrued liabilities		622			505
Deferred revenue		377			258
Short-term capital lease		4			4
Total current liabilities		2,498			2,392
Long-term debt, net		1,284			707
Deferred revenue long-term		210			315
Long-term capital lease		7			9
Other long-term liabilities		7			13
Total liabilities		4,006			3,436
Commitments and contingencies
Deficit:
Common stock, $0.01 par value; 20,000 shares authorized; 5,762 shares issued and outstanding at September 30, 2017 and December 31, 2016		58			58
Treasury shares, 5 at September 30, 2017 and December 31, 2016		(325	)		(325	)
Additional paid-in capital		128,983			128,884
Accumulated deficit		(131,839	)		(130,615	)
Accumulated other comprehensive loss		(14	)		(14	)
Total iSign stockholders' deficit		(3,137	)		(2,012	)
Non-controlling interest		(536	)		(536	)
Total deficit		(3,673	)		(2,548	)
Total liabilities and deficit	$	333		$	888

See accompanying notes to these Unaudited Condensed Consolidated Financial Statements

iSign Solutions Inc.

Condensed Consolidated Statements of Operations

Unaudited

(In thousands, except per share amounts)

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2017			2016			2017			2016
Revenue:
Product	$	65		$	50		$	157		$	273
Maintenance		165			171			498			580
Total revenue		230			221			655			853

Operating costs and expenses:
Cost of sales:
Product		4			12			11			66
Maintenance		23			77			92			294
Research and development		299			282			884			968
Sales and marketing		28			52			136			381
General and administrative		241			368			920			1,709
Total operating costs and expenses		595			791			2,043			3,418

Loss from operations		(365	)		(570	)		(1,388	)		(2,565	)

Other income (expense), net		(5	)		1			68			(11	)
Gain on sale of intangible asset		-			-			239			-
Interest expense:
Related party		(6	)		(10	)		(18	)		(91	)
Other		(23	)		(9	)		(53	)		(107	)
Amortization of debt discount:
Related party		(6	)		(2	)		(20	)		(58	)
Other		(18	)		(15	)		(52	)		(225	)

Gain on derivative liability		-			156			-			330
Net loss		(423	)		(449	)		(1,224	)		(2,727	)

Accretion of beneficial conversion feature: Preferred Stock:
Related party		-			-			-			(115	)
Other		-			-			-			(130	)

Preferred stock dividends:
Related party		-			-			-			(646	)
Other		-			-			-			(667	)
Net loss attributable to common stockholders	$	(423	)	$	(449	)	$	(1,224	)	$	(4,285	)
Basic and diluted net loss per common share	$	(0.07	)	$	(0.08	)	$	(0.21	)	$	(1.53	)
Weighted average common shares outstanding,basic and diluted		5,762			5,498			5,762			2,794

See accompanying notes to these Unaudited Condensed Consolidated Financial Statements

iSign Solutions Inc.

Condensed Consolidated Statements of Cash Flows

Unaudited

(In thousands)

	Nine Months Ended September 30,
	2017			2016
Cash flows from operating activities:
Net loss	$	(1,224	)	$	(2,727	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		252			276
Debt discount amortization		72			283
Stock-based compensation		99			139
Gain on sale of intangible asset		(239	)		-
Gain on derivative liability		-			(330	)
Changes in operating assets and liabilities:
Accounts receivable		54			(75	)
Prepaid expenses and other assets		26			307
Accounts payable		(73	)		602
Accrued compensation		(57	)		1
Other accrued and long-term liabilities		109			369
Deferred revenue		14			(115	)
Net cash used in operating activities		(967	)		(1,270	)

Cash flows from investing activities:
Acquisition of property and equipment		(2	)		-
Net cash used in investing activities		(2	)		-

Cash flows from financing activities:
Proceeds from issuance of short-term notes payable		-			100
Proceeds from issuance of long-term notes		505			240
Proceeds from the sale of intangible assets		239			-
Proceeds from issuance of common stock and warrants, net of issuance costs of $780		-			424
Payment of short-term debt		-			(200	)
Net cash provided by financing activities		744			564

Net decrease in cash and cash equivalents		(225	)		(706	)
Cash and cash equivalents at beginning of period		389			846
Cash and cash equivalents at end of period	$	164		$	140

See accompanying notes to these Unaudited Condensed Consolidated Financial Statements

iSign Solutions Inc.

Condensed Consolidated Statements of Cash Flows (Continued)

Unaudited

(In thousands)

	Nine Months Ended September 30,
	2017		2016
Supplementary disclosure of cash flow information
Interest paid	$	9	$	40
Income tax paid	$	-	$	-

Non-cash financing and investing transactions
Acquisition of property and equipment through capital lease	$		$	15
Discount on long term notes payable	$		$	103
Conversion of convertible notes plus accrued interest into 683 shares of Common Stock	$		$	1,188
Conversion of deferred compensation plus accrued interest into 286 shares of Common Stock	$		$	498
Exchange of long-term unsecured convertible promissory notes for long-term unsecured convertible promissory notes	$	200	$	-
Exchange of long-term unsecured convertible promissory notes for long-term secured convertible promissory notes	$	250	$	-

Dividends on Preferred Stock	$		$	1,313
Accretion of beneficial conversion feature on issuance of Preferred Stock	$		$	-
Accretion of beneficial conversion feature on issuance of Preferred Stock dividends	$		$	245

See accompanying notes to these Unaudited Condensed Consolidated Financial Statements

iSign Solutions Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

(In thousands, except per share amounts)

FORM 10-Q

Nature of business and summary of significant accounting policies

Nature of Business

iSign Solutions Inc. and its subsidiary is a leading supplier of digital transaction management (DTM) software enabling the paperless, secure and cost-effective management and authentication of document-based transactions. iSign’s solutions encompass a wide array of functionality and services, including electronic signatures, simple-to-complex workflow management and various options for biometric authentication. These solutions are available across virtually all enterprise, desktop and mobile environments as a seamlessly integrated platform for both ad-hoc and fully automated transactions. iSign’s platform can be deployed both on premise and as a cloud-based service, with the ability to easily transition between deployment models. The Company is headquartered in San Jose, California. The Company’s products include SignatureOne® Ceremony™ Server, the iSign® suite of products and services, including iSign® Enterprise and iSign® Console™, and Sign-it® programs.

Basis of Presentation

The financial information contained herein should be read in conjunction with the Company's consolidated audited financial statements and notes thereto included in its Annual Report on Form 10-K for the year ended December 31, 2016.

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America (“GAAP”) for complete consolidated financial statements. In the opinion of management, the unaudited condensed consolidated financial statements included in this quarterly report reflect all adjustments (consisting only of normal recurring adjustments) that the Company considers necessary for a fair presentation of its financial position at the dates presented and the Company’s results of operations and cash flows for the periods presented. The Company’s interim results are not necessarily indicative of the results to be expected for the entire year.

Going Concern

The accompanying unaudited condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has incurred significant cumulative losses since its inception and, at September 30, 2017, the Company’s accumulated deficit was $131,839. The Company has primarily met its working capital needs through the sale of debt and equity securities. As of September 30, 2017, the Company’s cash balance was $164. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

There can be no assurance that the Company will be successful in securing adequate capital resources to fund planned operations or that any additional funds will be available to the Company when needed, or if available, will be available on favorable terms or in amounts required by the Company. If the Company is unable to obtain adequate capital resources to fund operations, it may be required to delay, scale back or eliminate some or all of its operations, which may have a material adverse effect on the Company's business, results of operations and ability to operate as a going concern. The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

iSign Solutions Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

(In thousands, except per share amounts)

FORM 10-Q

Concentrations

The following table summarizes accounts receivable and revenue concentrations:

	Accounts Receivable As of September 30,						Total Revenue for the three months ended September 30,						Total Revenue for the nine months ended September 30,
	2017			2016			2017			2016			2017			2016
Customer #1		53	%		13	%		10	%		-			10	%		-
Customer #2		18	%		-			-			-			-			-
Customer #3		-			-			14	%		14	%		14	%		12	%
Customer #4		-			56	%		15	%		16	%		16	%		24	%
Customer #5		-			-			15	%		16	%		16	%		12	%
Customer #6		-			17	%		-			-			-			-
Customer #7		25	%		-			-			-			-			-
Total concentration		96	%		86	%		54	%		46	%		56	%		48	%

Intangible Assets

The Company performs an intangible asset impairment analysis at least annually or whenever circumstances or events indicate such assets might be impaired. The Company would recognize an impairment charge in the event the net book value of such assets exceeded the future undiscounted cash flows attributable to such assets.

Management completed an analysis of the Company’s intangible assets as of December 31, 2016. Based on that analysis, the Company concluded that no impairment of the carrying value of the intangible assets existed. The Company believes that no events or circumstances changed during the three and nine months ended September 30, 2017 that would impact this conclusion.

Amortization of intangible asset costs was $81 and $242 for the three and nine-month periods ended September 30, 2017 and $81 and $242 for the three and nine-month periods ended September 30, 2016.

The following table summarizes the intangible assets:

	September 30, 2017							December 31, 2016
	Carrying Amount		Accumulated Amortization			Net Value		Carrying Amount		Accumulated Amortization			Net Value
Amortizable intangible assets
Technology	$	6,745	$	(6,718	)	$	27	$	6,745	$	(6,476	)	$	269

Net loss per share

The Company calculates basic net loss per share based on the weighted average number of shares outstanding, and when applicable, diluted net income per share, which is based on the weighted average number of shares and potential dilutive shares outstanding.

iSign Solutions Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

(In thousands, except per share amounts)

FORM 10-Q

Net loss per share (continued)

The following table lists shares and warrants that were excluded from the calculation of diluted earnings per share as the exercise of such options and warrants would be antidilutive:

	For the Three and Nine Months Ended
	September 30, 2017		September 30, 2016

Stock options		566		71
Warrants		1,878		1,756

Debt

Advances:

In February 2017, the Company received, from investors and affiliates of the Company, advances aggregating $120 in cash against certain accounts receivable of the Company. Upon collection of an invoice, the Company would repay the advance to the lenders on a pro rata basis together with a 5% advance fee. The receivables were collected and the advances were repaid in March 2017, along with $6 in advance fees per the agreement. The advance fees were recorded as interest expense in the quarter ended March 31, 2017.

Notes payable:

In November 2016, the Company issued long-term unsecured convertible promissory notes to investors and affiliates of the Company aggregating $700 in cash. The Company also issued the same long-term notes to affiliates in exchange for an aggregate of $200 in demand notes that had been issued earlier in September and October of 2016. The long-term notes are mandatorily convertible into Common Stock at a conversion rate of the lesser of $1.30 per share or the price per share of Common Stock, upon closing a new debt and or equity financing of at least $1,000 in aggregate proceeds. The notes bear interest at the rate of 6% per annum and are due December 31, 2018. The Company issued warrants to purchase 277 shares of Common Stock in connection with these long-term notes. The Company ascribed a value of $204 to the 277 warrants and recorded a discount to the long-term notes and a corresponding amount to additional paid-in capital. The discount is being amortized using the effective interest method over the term of the notes.

In May 2017, the Company issued long-term secured convertible promissory notes to investors and affiliates of the Company aggregating $505 in cash. In addition, certain investors and affiliates of the Company that had taken part in the November 2016 financing discussed above and that also participated in the May 2017 financing, exchanged $250 of unsecured convertible promissory notes received in the November 2016 financing for the same secured notes issued in the May 2017 financing. The secured notes are mandatorily convertible into Common Stock at a conversion rate of the lesser of $0.50 per share or the price per share of Common Stock, upon closing a new financing of at least $1,000 in aggregate proceeds. The secured notes bear interest at the rate of 10% per annum, are due December 31, 2018 and are secured by an interest in all the Company's rights, title and interest in, to and under its intellectual property. Should the secured notes remain outstanding following the maturity date an additional 30% of the note’s principal amount shall become due and payable.

The Company used the funds received from the above financing for working capital and general corporate purposes.

The Company recorded $24 and $72 in debt discount amortization for the three and nine months ended September 30, 2017, respectively, related to the above 2016 debt financings.

iSign Solutions Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

(In thousands, except per share amounts)

FORM 10-Q

Equity (Deficit)

Stock-based compensation expense is based on the estimated grant date fair value of the portion of stock-based payment awards that are ultimately expected to vest during the period. The grant date fair value of stock-based awards to employees and directors is calculated using the Black-Scholes-Merton valuation model.

The weighted-average fair value of stock-based compensation is based on the Black-Scholes-Merton valuation model. Forfeitures are estimated and it is assumed no dividends will be declared. The estimated fair value of stock-based compensation awards to employees is amortized using the accrual method over the vesting period of the options.

The Company granted 502 stock options during the nine months ended September 30, 2017 at a weighted average exercise price of $0.50 per share. There were no stock options exercised during the three and nine months ended September 30, 2017.

There were no stock options granted, and no stock options exercised during the three and nine months ended September 30, 2016.

The fair value calculations for the stock options granted are based on the following assumptions:

	Nine Months Ended September 30, 2017
Risk free interest rate		1.56	%
Expected life (years)		5.3
Expected volatility		212.15	%
Expected dividends		None

The following table summarizes the allocation of stock-based compensation expense related to stock option grants for the three and nine-month periods ended September 30, 2017 and 2016.

	Three Months Ended September 30,				Nine Months Ended September 30,
	2017		2016		2017		2016
Research and development	$	15	$	12	$	35	$	46
Sales and marketing		-		-		-		15
General and administrative		19		15		39		59
Director options		10		5		25		19
Stock-based compensation expense	$	44	$	32	$	99	$	139

iSign Solutions Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

(In thousands, except per share amounts)

FORM 10-Q

Equity (Deficit) (continued)

A summary of option activity under the Company’s plans as of September 30, 2017 and 2016 is as follows:

	2017									2016
Options	Shares			Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value		Shares			Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value
Outstanding at January 1,		71		$	45.21			$	-		82		$	45.35			$	-
Granted		502		$	0.50			$	-		-		$	-			$	-
Forfeited or expired		(7	)	$	7.21			$	-		(11	)	$	45.66			$	-
Outstanding at September 30		566		$	6.02		6.09	$	-		71		$	45.30		3.41	$	-
Vested and expected to vest at September 30		520		$	6.04		6.04	$	-		70		$	46.14		3.36	$	-
Exercisable at September 30		106		$	29.05		3.92	$	-		58		$	49.70		2.95	$	-

The following table summarizes significant ranges of outstanding and exercisable options as of September 30, 2017:

	Options Outstanding						Options Exercisable
Range of Exercise Prices	Number Outstanding		Weighted Average Remaining Contractual Life (in years)		Weighted Average Exercise Price Per Share		Number Outstanding		Weighted Average Exercise Price Per Share
$0.01 – $25.00		498		6.60	$	0.56		42	$	1.02
$25.01 - $625.00		68		2.33	$	46.17		64	$	47.25
Total		566		6.09	$	6.02		106	$	29.05

The following table summarizes the Company’s non-vested option shares as of September 30, 2017:

Non-vested Option Shares	Shares			Weighted Average Grant-Date Fair Value
Non-vested at January 1, 2017		11		$	23.01
Granted		502		$	0.50
Forfeited		(6	)	$	0.75
Vested		(47	)	$	0.99
Non-vested at September 30, 2017		460		$	0.76

As of September 30, 2017, there was $101 of total unrecognized compensation expense related to non-vested stock-based compensation arrangements granted under the plans. The unrecognized compensation expense is expected to be realized over a weighted average period of 2.1 years.

iSign Solutions Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

(In thousands, except per share amounts)

FORM 10-Q

Equity (Deficit) (continued)

Warrants

A summary of the warrant activity for the nine months ended September 30 is as follows:

	September 30, 2017					September 30, 2016
	Shares			Weighted Average Exercise Price Per Share		Shares		Weighted Average Exercise Price Per Share
Outstanding at beginning of period		1,882		$	2.52		205	$	35.51
Issued		-		$	-		1,551	$	2.18
Expired		(4	)	$	34.38		-	$	-
Outstanding at end of period		1,878		$	1.53		1,756	$	5.27
Exercisable at end of period		1,878		$	1.53		1,756	$	5.27

A summary of the status of the warrants outstanding and exercisable as of September 30, 2017 is as follows:

Number of shares exercisable under Warrants		Weighted Average Remaining Life Years		Weighted Average Exercise Price per share

	50		0.01	$	0.42
	277		0.42	$	0.24
	1,551		3.04	$	1.80
	1,878		2.57	$	1.53

iSign Solutions Inc.

(In thousands, except per share amounts)

FORM 10-Q

Forward Looking Statements

Certain statements contained in this quarterly report on Form 10-Q, including, without limitation, statements containing the words “believes”, “anticipates”, “hopes”, “intends”, “expects”, and other words of similar import, constitute “forward looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors which may cause actual events to differ materially from expectations. Such factors include those set forth in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016, including the following:

●

Technological, engineering, manufacturing, quality control or other circumstances that could delay the sale or shipment of products;

●

Economic, business, market and competitive conditions in the software industry and technological innovations that could affect the Company’s business;

●

The Company’s inability to protect its trade secrets or other proprietary rights, operate without infringing upon the proprietary rights of others and prevent others from infringing on the proprietary rights of the Company; and

●

General economic and business conditions and the availability of sufficient financing.

Except as otherwise required by applicable laws, the Company undertakes no obligation to publicly update or revise any forward-looking statements, as a result of new information, future events or otherwise.

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion and analysis should be read in conjunction with the Company’s unaudited condensed consolidated financial statements and notes thereto included in Part 1, Item 1 of this quarterly report on Form 10-Q and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” set forth in the Company’s Annual report on Form 10-K for the fiscal year ended December 31, 2016.

Overview

The Company is a leading supplier of digital transaction management (DTM) software enabling the paperless, secure and cost-effective management of document-based transactions. iSign’s solutions encompass a wide array of functionality and services, including electronic signatures, biometric authentication and simple-to-complex workflow management. These solutions are available across virtually all enterprise, desktop and mobile environments as a seamlessly integrated platform for both ad-hoc and fully automated transactions. iSign’s software can be deployed both on premise and as a cloud-based service, with the ability to easily transition between deployment models.

The Company was incorporated in Delaware in October 1986. Except for the year ended December 31, 2004, in each year since its inception the Company has incurred losses. For the two-year period ended December 31, 2016, net losses attributable to common stockholders aggregated approximately $12,676, and, at September 30, 2017, the Company's accumulated deficit was approximately $131,839.

For the three months ended September 30, 2017, total revenue was $230, an increase of $9, or 4%, compared to total revenue of $221 in the prior year period. For the nine months ended September 30, 2017, total revenue was $655, a decrease of $198, or 23%, compared to total revenue of $853 in the prior year period. The increase in revenue for the three months ended September 30, 2017 is due to higher product revenue partially offset by a decrease in maintenance revenue. The decrease in revenue for the nine months ended September 30, 2017 is due to decreases in both product and maintenance revenue compared to the prior year.

For the three months ended September 30, 2017, the loss from operations was $365, a decrease of $205, or 36%, compared with a loss from operations of $570 in the prior year period. The decrease in the loss for the three months ended September 30, 2017 was due primarily to cost reductions put in place in the beginning of 2016. For the nine months ended September 30, 2017, the loss from operations was $1,388, a decrease of $1,177, or 46%, compared with a loss from operations of $2,565 in the prior year period. The decrease in the loss from operations for the nine months ended September 30, 2017 is primarily attributable to the same factors discussed above.

iSign Solutions Inc.

(In thousands, except per share amounts)

FORM 10-Q

Critical Accounting Policies and Estimates

Refer to Item 7, “Management Discussion and Analysis of Financial Condition and Results of Operations” in the Company’s 2016 Form 10-K.

Results of Operations

Revenue

For the three months ended September 30, 2017, product revenue was $65, an increase of $15, or 30%, compared to product revenue of $50 in the prior year period. The increase in product revenue is primarily due to an increase in product licensing revenue. For the three months ended September 30, 2017, maintenance revenue was $165, a decrease of $6, or 4%, compared to maintenance revenue of $171 in the prior year period. This decrease is primarily due to the non-renewal of certain maintenance contracts.

For the nine months ended September 30, 2017, product revenue was $157, a decrease of $116, or 42%, compared to product revenue of $273 in the prior year period. The decrease in product revenue is primarily attributable to a reduction in product licensing sales compared to the prior year. For the nine months ended September 30, 2017, maintenance revenue was $498, a decrease of $82, or 14%, compared to maintenance revenue of $580 in the prior year period. The decrease in maintenance revenue is primarily due to the factors discussed for the three-month period above.

Cost of Sales

For the three months ended September 30, 2017, cost of sales was $27, a decrease of $62, or 70%, compared to cost of sales of $89 in the prior year period. The decrease in cost of sales was primarily due to a decrease in direct labor related to maintenance revenue generating contracts during the three months ended September 30, 2017 compared to the prior year period.

For the nine months ended September 30, 2017, cost of sales was $103, a decrease of $257, or 71%, compared to cost of sales of $360 in the prior year period. The decrease in cost of sales was due to a decrease in direct labor related to transactional and maintenance revenue generating contracts compared to the prior year period.

Operating expenses

Research and Development Expenses

For the three months ended September 30, 2017, research and development expense was $299, an increase of $17, or 6%, compared to research and development expense of $282 in the prior year period. Research and development expenses consist primarily of salaries and related costs, outside engineering, maintenance items, and allocated facilities expenses. Research and development expenses increased primarily due to lower allocation of labor costs to cost of sales in comparison to the prior year. Total expenses, before allocations for the three months ended September 30, 2017, were $340, a decrease of $41, or 11%, compared to $381 in the prior year period.

For the nine months ended September 30, 2017, research and development expense was $884, a decrease of $84, or 9%, compared to research and development expense of $968 in the prior year period. The most significant factors in the decrease include a decrease in total salaries and benefits due to the reduction of one engineer in the third quarter of the prior year and reduction in the time commitment of a second engineer working part time. Total expenses, before allocations to cost of sales, for the nine months ended September 30, 2017, were $1,028 a decrease of $340, or 25%, compared to $1,368 in the prior year period.

iSign Solutions Inc.

(In thousands, except per share amounts)

FORM 10-Q

Sales and Marketing Expense

For the three months ended September 30, 2017, sales and marketing expense was $28, a decrease of $24, or 46%, compared to sales and marketing expense of $52 in the prior year period. For the nine months ended September 30, 2017, sales and marketing expense was $136, a decrease of $245, or 64%, compared to sales and marketing expense of $381 in the prior year period. These decreases were primarily attributable to salary and related cost savings implemented in 2016 as part of the Company’s transition to a go to market strategy principally focused on partner integrations.

General and Administrative Expense

For the three months ended September 30, 2017, general and administrative expense was $241, a decrease of $127, or 35%, compared to general and administrative expense of $368 in the prior year period. The decrease was primarily due to reductions in salaries and related expense and professional services including legal and accounting fees compared to the prior year period.

For the nine months ended September 30, 2017, general and administrative expense was $920, a decrease of $789, or 46%, compared to general and administrative expense of $1,709 in the prior year period. The decrease was primarily due to lower legal, accounting and other offering expenses related to the public offering that was completed May 2016, as well as decreases in salaries and certain related expense.

Other Income and Expense, net

For the nine-months ended September 30, 2017, the Company recorded a gain on sale of the source code and rights to one of the Company’s older toolkit software products, net of related costs, of $239. The purchaser granted the Company a fully-paid, royalty-free, worldwide, irrevocable license to use the software to support current and existing customers and partners of the Company. The Company did not retain the right to distribute the software either as a source code or as an object code. However, the Company retained the right to create new non- toolkit software from the original source code and to market, sell and distribute the new non- toolkit software in the ordinary course of business to its customers and partners.

For the three months ended September 30, 2017, interest expense was $29, an increase of $10, compared to interest expense of $19 in the prior year period. The increase is due to an increase in long-term debt compared to the prior year period.

For the nine months ended September 30, 2017, interest expense was $71, a decrease of $127, compared to interest expense of $198 in the prior year period. The decrease was due to the conversion of long-term debt into common stock of the Company in May of 2016.

For the three months ended September 30, 2017, amortization of debt discount was $24, an increase of $7, compared to $17 in the prior year period. The increase was due to the amortization of the warrants issued along with long-term debt in November of 2016.

For the nine months ended September 30, 2017, amortization of debt discount was $72, a decrease of $211, compared to $283 in the prior year period. The decrease was due to the write-off of un-amortized debt discount associated with the conversion of notes payable into shares of Common Stock in May 2016.

For the three and nine months ended September 30, 2017, the gain on derivative liability was $0, a decrease of $156 and $330, respectively, compared to prior year periods.

iSign Solutions Inc.

(In thousands, except per share amounts)

FORM 10-Q

Liquidity and Capital Resources

At September 30, 2017, cash and cash equivalents totaled $164, compared to cash and cash equivalents of $389 at December 31, 2016. The decrease in cash was primarily due to net cash used in operating activities of $967 and the acquisition of property and equipment of $2. The use of cash was partially offset by the proceeds from the issuance of $505 in long-term debt during the nine-month period and the $239 in proceeds from the sale of intangible assets during the nine months ended September 30, 2017. At September 30, 2017, total current assets were $277, compared to total current assets of $582 at December 31, 2016. At September 30, 2017, the Company's principal sources of funds included its aggregated cash and cash equivalents of $164.

At September 30, 2017, accounts receivable net, was $83, a decrease of $54, or 39%, compared to accounts receivable net of $137 at December 31, 2016. The decrease is due primarily to the timing of billings during the three months ended September 30, 2017.

At September 30, 2017, prepaid expenses and other current assets were $30, a decrease of $26, or 46%, compared to prepaid expenses and other current assets of $56 at December 31, 2016. The decrease is due primarily to the expensing of prepaid director and officer insurance premiums during the nine-month period. At September 30, 2017, total current liabilities were $2,498, an increase of $106, or 4%, compared to total current liabilities of $2,392 at December 31, 2016. At September 30, 2017, accounts payable was $1,295, a decrease of $73, or 5%, compared to accounts payable of $1,368 at December 31, 2016. At September 30, 2017, accrued compensation was $200, a decrease of $57, or 22%, compared to accrued compensation of $257 at December 31, 2016. The decreases are due primarily to cost saving measures put in place by the Company. Other accrued liabilities were $622, an increase of $117, or 23%, from $505 at December 31, 2016 due primarily to the accrual of additional deferred professional services.

At September 30, 2017, current deferred revenue as of September 30, 2017 was $377, an increase of $119, or 46%, compared to current deferred revenue of $258 at December 31, 2016. Deferred revenue primarily reflects advance payments for maintenance fees from the Company's licensees that are generally recognized as revenue by the Company when all obligations are met or over the term of the maintenance agreement, whichever is longer. Deferred revenue is recorded when the Company receives advance payment from its customers.

In February 2017, the Company received, from investors and affiliates of the Company, advances aggregating $120 in cash against certain accounts receivable of the Company. Upon collection of an invoice, the Company would repay the advance to the lenders on a pro rata basis together with a 5% advance fee. The Company used the funds received from the above advances for working capital and general corporate purposes. The receivables were collected and the advances were repaid in March 2017, along with $6 in advance fees per the agreement.

In May 2017, the Company issued long-term secured convertible promissory notes to investors and affiliates of the Company aggregating $505 in cash. In addition, certain investors and affiliates of the Company that had taken part in the November 2016 financing discussed above and that also participated in the May 2017 financing, exchanged $250 of unsecured convertible promissory notes received in the November 2016 financing for $250 of the same secured notes issued in the May 2017 financing. The secured notes are mandatorily convertible into Common Stock at a conversion rate of the lesser of $.50 per share or the price per share of Common Stock, upon closing a new financing of at least $1,000 in aggregate proceeds. The secured notes bear interest at the rate of 10% per annum, are due December 31, 2018 and are secured by an interest in all the Company's right, title and interest in, to and under its intellectual property. Should the secured notes remain outstanding following the maturity date an additional 30% of the note’s principal amount shall become due and payable.

The Company is using the funds received from the above financing for working capital and general corporate purposes.

The Company recorded $24 and $72 in debt discount amortization for the three and nine months ended September 30, 2017, respectively, related to the 2016 debt financings.

The Company incurred $29 and $71, respectively, of interest expense for the three and nine months ended September 30, 2017, of which $3 and $9, respectively were paid in cash.

iSign Solutions Inc.

(In thousands, except per share amounts)

FORM 10-Q

The Company had the following material commitments as of September 30, 2017:

Contractual obligations	Total		2017		2018		2019		2020
Operating lease commitments (1)	$	213	$	25	$	101	$	87	$	─
Capital lease commitments		15		1		6		6		2
	$	228	$	26	$	107	$	93	$	2

In November 2016, the Company moved its principal facilities to San Jose, California, pursuant to a lease that expires in 2019. In addition to monthly rent, the facilities are subject to additional rental payments for utilities and other costs above the base amount.

The Company has experienced recurring losses from operations that raise a substantial doubt about its ability to continue as a going concern. There can be no assurance that the Company will have adequate capital resources to fund planned operations or that any additional funds will be available to it when needed, or if available, will be available on favorable terms or in amounts required by it. If the Company is unable to obtain adequate capital resources to fund operations, it may be required to delay, scale back or eliminate some or all of its operations, which may have a material adverse effect on the Company's business, results of operations and ability to operate as a going concern.

iSign Solutions Inc.

(In thousands, except per share amounts)

FORM 10-Q

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

Interest Rate Risk

The Company did not enter into any short-term security investments during the three and nine months ended September 30, 2017.

Foreign Currency Risk

From time to time, the Company makes certain capital equipment or other purchases denominated in foreign currencies. As a result, the Company’s cash flows and earnings are exposed to fluctuations in interest rates and foreign currency exchange rates. The Company attempts to limit these exposures through operational strategies and generally has not hedged currency exposures. During the three and nine months ended September 30, 2017 and 2016, foreign currency translation gains and losses were insignificant.

Item 4. Controls and Procedures.

Disclosure Controls and Procedures

As of the end of the period covered by this report, we conducted an evaluation under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, of the effectiveness of our disclosure controls and procedures pursuant to paragraph (b) of Rule 13a-15 and 15d-15 under the Exchange Act of 1934 (the “Exchange Act”). Based on that evaluation our Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were effective to ensure that the information required to be disclosed in reports we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosures.

Our management, including our Chief Executive Officer and Chief Financial Officer, do not expect that our disclosure controls and procedures will prevent all errors or fraud. A control procedure, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control procedures are met. Because of the inherent limitations in all control procedures, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The Company considered these limitations during the development of its disclosure controls and procedures, and will continually reevaluate them to ensure they provide reasonable assurance that such controls and procedures are effective.

Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting during the quarter ended September 30, 2017 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Part II-Other Information

Item 1. Legal Proceedings

On September 20, 2017, a vendor of the Company filed a stipulation for entry of judgment in the event of default on a payment plan related to past due fees, and a stipulation to dismiss without prejudice with the court retaining jurisdiction to enforce the settlement. The Company has to date complied with the terms of the settlement, and will continue to do so until the final payment is made.

iSign Solutions Inc.

(In thousands, except per share amounts)

FORM 10-Q

Part II-Other Information (Continued)

Item 1A. Risk Factors

Not applicable.

Item 2. Unregistered Sale of Securities and Use of Proceeds

None.

Item 3. Defaults upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

Item 6. Exhibits.

(a)

Exhibits.

Exhibit Number		Document
3.1		Certificate of Incorporation of the Company, as amended, incorporated herein by reference to Exhibits 3.1, 3.2, 3.3 and 3.4 to the Company's Registration Statement on Form 10 (File No. 0-19301).
3.2		Certificate of Amendment to the Company's Certificate of Incorporation (authorizing the reclassification of the Class A Common Stock and Class B Common Stock into one class of Common Stock) as filed with the Delaware Secretary of State's office on November 1, 1991, incorporated herein by reference to Exhibit 3 to Amendment 1 on Form 8 to the Company's Form 8-A (File No. 0-19301).
3.3		By-laws of the Company adopted on October 6, 1986, incorporated herein by reference to Exhibit 3.5 to the Company's Registration Statement on Form 10 (File No. 0-19301).
3.4		By-laws of the Company adopted on October 6, 1986, incorporated herein by reference to Exhibit 3.5 to the Company's Registration Statement on Form 10 (File No. 0-19301).
3.5		Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation dated January 24, 2001, incorporated herein by reference to Exhibit 3.5 to the Company’s Registration Statement on Form S/1, filed December 28, 2007.
3.6		Certificate of Elimination of the Company’s Certificate of Designation of the Series A Preferred Stock dated August 17, 2001, incorporated herein by reference to Exhibit 3.6 to the Company’s Registration Statement on Form S/1, filed December 28, 2007.
3.7		Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation filed with the Delaware Secretary of State August 17, 2007, incorporated herein by reference to Exhibit 3.7 to the Company’s Registration Statement on Form S/1 filed on December 28, 2007.
3.8		Amended and Restated Certificate of Incorporation of the Company filed with the Delaware Secretary of State on May 18, 1995, incorporated herein by reference to Exhibit 3.2 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2008.

iSign Solutions Inc.

(In thousands, except per share amounts)

FORM 10-Q

Exhibit Number		Document
3.9		Certificate of Designations, Powers, Preferences and Rights of the Series A Cumulative Convertible Preferred Stock filed with the Delaware Secretary of State on June 4, 2008, incorporated herein by reference to Exhibit 4.23 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2008.
3.10		Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation filed with the Delaware Secretary of State on June 30, 2008, incorporated herein by reference to Exhibit 3.7 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2008.
3.11		Certificate of Designations, Powers, Preferences and Rights of the Series A-1 Cumulative Convertible Preferred Stock filed with the Delaware Secretary of State on October 30, 2008, incorporated herein by reference to Exhibit 3.11 to the Company’s Annual Report on Form 10-K filed on March 12, 2009.
3.12		Certificate of Elimination of the Company’s Series A Cumulative Convertible Preferred Stock filed with the Delaware Secretary of State on December 30, 2008, incorporated herein by reference to Exhibit 3.12 to the Company’s Annual Report on Form 10-K filed on March 12, 2009.
3.13		Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation filed with the Delaware Secretary of State on June 30, 2009, incorporated herein by reference to Exhibit 3.13 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2009.
3.14		Amendment No. 1 to By-laws dated June 17, 2010, incorporated herein by reference to Exhibit 3.14 to the Company’s Quarterly Report on Form 10-Q filed on August 16, 2010.
3.15		Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation filed with the Delaware Secretary of State on August 4, 2010, incorporated herein by reference to Exhibit 3.15 to the Company’s Quarterly Report on Form 10-Q filed on November 12, 2010.
3.16		Amended and Restated Certificate of Designation of Series A-1 Cumulative Convertible Preferred Stock filed with the Delaware Secretary of State on August 4, 2010, incorporated herein by reference to Exhibit 3.16 to the Company’s Quarterly Report on Form 10-Q filed on November 12, 2010.
3.17		Certificate of Designation of Series B Participating Convertible Preferred Stock filed with the Delaware Secretary of State on August 4, 2010, incorporated herein by reference to Exhibit 3.17 to the Company’s Quarterly Report on Form 10-Q filed on November 12, 2010.
3.18		Certificate of Amendment to Amended And Restated Certificate of Incorporation filed with the Delaware Secretary of State on December 31, 2010, incorporated herein by reference to Exhibit 3.18 to the Company’s Annual Report on Form 10-K filed on March 30, 2011.
3.19		Second Amended and Restated Certificate of Designation of Series A-1 Cumulative Convertible Preferred Stock filed with the Delaware Secretary of State on December 31, 2010, incorporated herein by reference to Exhibit 3.19 to the Company’s Annual Report on Form 10-K filed on March 30, 2011.
3.20		Second Amended and Restated Certificate of Designation of Series B Participating Convertible Preferred Stock filed with the Delaware Secretary of State on December 31, 2010, incorporated herein by reference to Exhibit 3.20 to the Company’s Annual Report on Form 10-K filed on March 30, 2011.
3.21		Certificate of Designation of Series C Participating Convertible Preferred Stock filed with the Delaware Secretary of State on December 31, 2010, incorporated herein by reference to Exhibit 3.21 to the Company’s Annual Report on Form 10-K filed on March 30, 2011.
3.22		Amendment to the Amended And Restated Certificate of Designation of the Series B Participating Convertible Preferred Stock, incorporated herein by reference to Exhibit 10.59 to the Company’s Current Report on Form 8-K filed March 31, 2011.
3.23		Amendment to the Amended And Restated Certificate of Designation of the Series C Participating Convertible Preferred Stock, incorporated herein by reference to Exhibit 10.60 to the Company’s Current Report on Form 8-K filed March 31, 2011.

iSign Solutions Inc.

(In thousands, except per share amounts)

FORM 10-Q

Exhibit Number		Document
3.24		Certificate of Amendment to Amended and Restated Certificate of Incorporation filed with the Delaware Secretary of State on November 13, 2012, incorporated herein by reference to Appendix A to the Company’s Definitive Proxy Statement filed on Schedule 14A on October 22, 2012.
3.25		Third Amended and Restated Certificate of Designation of Series A-1 Cumulative Convertible Preferred Stock filed with the Delaware Secretary of State on November 13, 2012, incorporated herein by reference to Exhibit 3.25 to the Company’s Form 10-K filed March 31, 2014.
3.26		Second Amended and Restated Certificate of Designation of Series B Participating Convertible Preferred Stock filed with the Delaware Secretary of State on November 13, 2012, incorporated herein by reference to Exhibit 3.26 to the Company’s Form 10-K filed March 31, 2014.
3.27		Amended and Restated Certificate of Designation of Series C Participating Convertible Preferred Stock filed with the Delaware Secretary of State on November 13, incorporated herein by reference to Exhibit 3.27 to the Company’s Form 10-K filed March 31, 2014.
3.28		Certificate of Designation of Series D Convertible Preferred Stock filed with the Delaware Secretary of State on November 13, 2012, incorporated herein by reference to Exhibit 3.28 to the Company’s Form 10-K filed March 31, 2014.
3.29		Certificate of Amendment to Amended and Restated Certificate of Incorporation filed with the Delaware Secretary of State on December 10, 2013, incorporated herein by reference to Appendix A to the Company’s Definitive Proxy Statement filed on Schedule 14A on November 1, 2013.
3.30		Certificate of Amendment to Certificate of Designation of Series D Convertible Preferred Stock filed with the Delaware Secretary of State on December 31, 2013, incorporated herein by reference to Exhibit 3.30 to the Company’s Form 10-K filed March 31, 2014.
3.31		Certificate of Amendment to Amended and Restated Certificate of Incorporation filed with the Delaware Secretary of State on December 16, 2014, incorporate herein by reference to Appendix A to the Company’s Definitive Proxy Statement filed on Schedule 14A on October 17, 2014.
3.32		Certificate of Amendment to Certificate of Designation of Series D Convertible Preferred Stock filed with the Delaware Secretary of State on March 24, 2015, incorporated herein by reference to Exhibit 3.32 to the Company’s Quarterly Report on Form 10-Q filed May 15, 2015.
3.33		Certificate of Amendment to the Company’s Third Amended and Restated Certificate of Designation of Series A-1 Cumulative Convertible Preferred Stock filed with Secretary of State of the State of Delaware on May 18, 2016, incorporated herein by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed May 19, 2016.
3.34		Certificate of Amendment to the Company’s Second Amended and Restated Certificate of Designation of Series B Participating Convertible Preferred Stock filed with Secretary of State of the State of Delaware on May 18, 2016, incorporated herein by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K filed May 19, 2016.
3.35		Certificate of Amendment to the Company’s Amended and Restated Certificate of Designation of Series C Participating Convertible Preferred Stock filed with Secretary of State of the State of Delaware on May 18, 2016, incorporated herein by reference to Exhibit 3.3 to the Company’s Current Report on Form 8-K filed May 19, 2016.
3.36		Certificate of Amendment to the Company’s Certificate of Designation of Series D Convertible Preferred Stock filed with Secretary of State of the State of Delaware on May 18, 2016, incorporated herein by reference to Exhibit 3.4 to the Company’s Current Report on Form 8-K filed May 19, 2016.
3.37		Certificate of Amendment to the Company’s Certificate of Designation of Series D Convertible Preferred Stock filed with Secretary of State of the State of Delaware on May 18, 2016, incorporated herein by reference to Exhibit 3.5 to the Company’s Current Report on Form 8-K filed May 19, 2016.
10.59		Amendment to the Amended And Restated Certificate of Designation of the Series B Participating Convertible Preferred Stock, incorporated herein by reference to Exhibit 10.59 to the Company’s Current Report on Form 8-K filed March 31, 2011.
10.60		Amendment to the Amended And Restated Certificate of Designation of the Series C Participating Convertible Preferred Stock, incorporated herein by reference to Exhibit 10.60 to the Company’s Current Report on Form 8-K filed March 31, 2011.

iSign Solutions Inc.

(In thousands, except per share amounts)

FORM 10-Q

Exhibit Number		Document
10.61		Form Of Subscription Agreement, incorporated herein by reference to Exhibit 10.61 to the Company’s Current Report on Form 8-K filed on April 4, 2011.
10.62		Amendment No. 1 to the Registration Rights Agreement dated March 31, 2011, incorporated herein by reference to Exhibit 10.62 to the Company’s Current Report on Form 8-K filed on April 4, 2011.
10.63		Note and Warrant Purchase Agreement dated April 23, 2012, incorporated herein by reference to Exhibit 10.63 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2012.
10.64		Form of Subscription Agreement dated September 14, 2012, incorporated herein by reference to Exhibit 10.64 to the Company’s Quarterly Report on Form 10-Q filed on November 14, 2012.
10.65		Form of Unsecured Convertible Promissory Note dated September 14, 2012, incorporated herein by reference to Exhibit 10.65 to the Company’s Quarterly Report on Form 10-Q filed on November 14, 2012.
10.66		Form of Subscription Agreement dated May 17, 2013, incorporated herein by reference to Exhibit 10.66 to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2013.
10.67		Form of Subscription Agreement dated December 31, 2013, incorporated herein by reference to Exhibit 10.67 to the Company’s Form 10-K filed March 31, 2014.
10.68		Credit Agreement with Venture Champion Asia Limited dated May 6, 2014, incorporated herein by reference to Exhibit 10.68 to the Company’s Form 10-Q filed August 15, 2014.
10.69		Form of Subscription Agreement dated August 5, 2014, incorporated herein by reference to Exhibit 10.69 to the Company’s Form 10-K filed March 31, 2015.
10.70		Form of Subscription Agreement dated March 24, 2015, incorporated herein by reference to Exhibit 10.70 to the Company’s Quarterly Report on Form 10-Q filed May 15, 2015.
10.71		Form of Subscription Agreement dated July 23, 2015, incorporated herein by reference to Exhibit 10.71 to the Company’s Quarterly Report on Form 10-Q filed November 16, 2015.
10.72		Note and Warrant Purchase Agreement dated November 3, 2016, incorporated herein by reference to Exhibit 10.72 to the Company’s Quarterly Report on Form 10-Q filed August 14, 2017.
10.73		Form of Unsecured Convertible Promissory Note dated November 3, 2016, incorporated herein by reference to Exhibit 10.73 to the Company’s Quarterly Report on Form 10-Q filed August 14, 2017.
10.74		Note Purchase Agreement dated May 23, 2017, incorporated herein by reference to Exhibit 10.74 to the Company’s Quarterly Report on Form 10-Q filed August 14, 2017.
10.75		Form of Secured Convertible Promissory Note dated May 23, 2017, incorporated herein by reference to Exhibit 10.75 to the Company’s Quarterly Report on Form 10-Q filed August 14, 2017.
*31.1		Certification of Company’s Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
*31.2		Certificate of Company’s Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
*32.1		Certification of Chief Executive Officer pursuant to 18 USC Section 1750, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
*32.2		Certification of Chief Financial Officer pursuant to 18 USC Section 1750, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

* Filed herewith.

iSign Solutions Inc.

(In thousands, except per share amounts)

FORM 10-Q

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		iSign Solutions Inc.
		Registrant

November 14, 2017		/s/ Andrea Goren
Date		Andrea Goren
		(Principal Financial Officer and Officer Duly Authorized to Sign on Behalf of the Registrant)

EX-31.1 2 f10q0917ex31-1_isignsol.htm CERTIFICATION

EXHIBIT 31.1

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Philip Sassower, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of iSign Solutions Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 14, 2017

/s/ Philip Sassower
Chairman and Chief Executive Officer
(Principal Executive Officer of Registrant)

EX-31.2 3 f10q0917ex31-2_isignsol.htm CERTIFICATION

EXHIBIT 31.2

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Andrea Goren, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of iSign Solutions Inc.;

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 14, 2017

/s/ Andrea Goren
Chief Financial Officer
(Principal Financial Officer of Registrant)

EX-32.1 4 f10q0917ex32-1_isignsol.htm CERTIFICATION

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Philip S. Sassower, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of iSign Solutions Inc. on Form 10-Q for the quarterly period ended September 30, 2017 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of iSign Solutions Inc.

Date: November 14, 2017

By:	/s/ Philip S. Sassower
Chairman and Chief Executive Officer
(Principal Executive Officer)

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to iSign Solutions Inc. and will be retained by iSign Solutions Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

This certification accompanies this Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by iSign Solutions Inc. for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that iSign Solutions Inc. specifically incorporates it by reference.

EX-32.2 5 f10q0917ex32-2_isignsol.htm CERTIFICATION

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Andrea Goren, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of iSign Solutions Inc. on Form 10-Q for the quarterly period ended September 30, 2017 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of iSign Solutions Inc.

Date: November 14, 2017

By:	/s/ Andrea Goren
Chief Financial Officer
(Principal Financial Officer)

EX-101.INS 6 isgn-20170930.xml XBRL INSTANCE FILE 0000727634 2015-12-31 0000727634 us-gaap:WarrantMember 2015-12-31 0000727634 2016-07-01 2016-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember isgn:CustomerFourMember 2016-07-01 2016-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember isgn:CustomerTwoMember 2016-07-01 2016-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember isgn:CustomerThreeMember 2016-07-01 2016-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember 2016-07-01 2016-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember isgn:CustomerFiveMember 2016-07-01 2016-09-30 0000727634 us-gaap:ResearchAndDevelopmentExpenseMember 2016-07-01 2016-09-30 0000727634 us-gaap:SellingAndMarketingExpenseMember 2016-07-01 2016-09-30 0000727634 us-gaap:GeneralAndAdministrativeExpenseMember 2016-07-01 2016-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember isgn:CustomerOneMember 2016-07-01 2016-09-30 0000727634 isgn:DirectorOptionsMember 2016-07-01 2016-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember isgn:CustomerSixMember 2016-07-01 2016-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember isgn:CustomerSevenMember 2016-07-01 2016-09-30 0000727634 2016-01-01 2016-09-30 0000727634 us-gaap:WarrantMember 2016-01-01 2016-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember isgn:CustomerFourMember 2016-01-01 2016-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember isgn:CustomerTwoMember 2016-01-01 2016-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember isgn:CustomerThreeMember 2016-01-01 2016-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember 2016-01-01 2016-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember isgn:CustomerFiveMember 2016-01-01 2016-09-30 0000727634 us-gaap:ResearchAndDevelopmentExpenseMember 2016-01-01 2016-09-30 0000727634 us-gaap:SellingAndMarketingExpenseMember 2016-01-01 2016-09-30 0000727634 us-gaap:GeneralAndAdministrativeExpenseMember 2016-01-01 2016-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember isgn:CustomerOneMember 2016-01-01 2016-09-30 0000727634 isgn:DirectorOptionsMember 2016-01-01 2016-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember isgn:CustomerSixMember 2016-01-01 2016-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember isgn:CustomerSevenMember 2016-01-01 2016-09-30 0000727634 us-gaap:AccountsReceivableMember isgn:CustomerOneMember 2016-01-01 2016-09-30 0000727634 us-gaap:AccountsReceivableMember isgn:CustomerFourMember 2016-01-01 2016-09-30 0000727634 us-gaap:AccountsReceivableMember isgn:CustomerTwoMember 2016-01-01 2016-09-30 0000727634 us-gaap:AccountsReceivableMember 2016-01-01 2016-09-30 0000727634 us-gaap:AccountsReceivableMember isgn:CustomerThreeMember 2016-01-01 2016-09-30 0000727634 us-gaap:AccountsReceivableMember isgn:CustomerFiveMember 2016-01-01 2016-09-30 0000727634 us-gaap:EmployeeStockOptionMember 2016-01-01 2016-09-30 0000727634 us-gaap:WarrantMember 2016-01-01 2016-09-30 0000727634 isgn:CommonStockAndWarrantsMember 2016-01-01 2016-09-30 0000727634 us-gaap:AccountsReceivableMember isgn:CustomerSixMember 2016-01-01 2016-09-30 0000727634 us-gaap:AccountsReceivableMember isgn:CustomerSevenMember 2016-01-01 2016-09-30 0000727634 2016-09-30 0000727634 us-gaap:WarrantMember 2016-09-30 0000727634 isgn:DemandPromissoryNotesMember isgn:InvestorsAndAffiliatesMember 2016-09-01 2016-09-30 0000727634 isgn:DemandPromissoryNotesMember isgn:InvestorsAndAffiliatesMember 2016-10-01 2016-10-31 0000727634 us-gaap:ConvertibleNotesPayableMember 2016-11-30 0000727634 us-gaap:ConvertibleDebtMember isgn:InvestorsAndAffiliatesMember 2016-11-30 0000727634 us-gaap:ConvertibleNotesPayableMember 2016-11-01 2016-11-30 0000727634 us-gaap:ConvertibleDebtMember isgn:InvestorsAndAffiliatesMember 2016-11-01 2016-11-30 0000727634 us-gaap:ConvertibleNotesPayableMember us-gaap:MaximumMember 2016-11-01 2016-11-30 0000727634 us-gaap:ConvertibleNotesPayableMember us-gaap:MinimumMember 2016-11-01 2016-11-30 0000727634 2016-12-31 0000727634 us-gaap:WarrantMember 2016-12-31 0000727634 us-gaap:TechnologyBasedIntangibleAssetsMember 2016-12-31 0000727634 us-gaap:DebtMember 2017-02-01 2017-02-28 0000727634 us-gaap:ConvertibleNotesPayableMember 2017-05-31 0000727634 us-gaap:ConvertibleNotesPayableMember 2017-05-01 2017-05-31 0000727634 us-gaap:ConvertibleDebtMember isgn:InvestorsAndAffiliatesMember 2017-05-01 2017-05-31 0000727634 2017-07-01 2017-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember isgn:CustomerFourMember 2017-07-01 2017-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember isgn:CustomerTwoMember 2017-07-01 2017-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember isgn:CustomerThreeMember 2017-07-01 2017-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember 2017-07-01 2017-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember isgn:CustomerFiveMember 2017-07-01 2017-09-30 0000727634 us-gaap:ResearchAndDevelopmentExpenseMember 2017-07-01 2017-09-30 0000727634 us-gaap:SellingAndMarketingExpenseMember 2017-07-01 2017-09-30 0000727634 us-gaap:GeneralAndAdministrativeExpenseMember 2017-07-01 2017-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember isgn:CustomerOneMember 2017-07-01 2017-09-30 0000727634 isgn:DirectorOptionsMember 2017-07-01 2017-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember isgn:CustomerSixMember 2017-07-01 2017-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember isgn:CustomerSevenMember 2017-07-01 2017-09-30 0000727634 us-gaap:ConvertibleNotesPayableMember 2017-07-01 2017-09-30 0000727634 2017-01-01 2017-09-30 0000727634 us-gaap:WarrantMember 2017-01-01 2017-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember isgn:CustomerFourMember 2017-01-01 2017-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember isgn:CustomerTwoMember 2017-01-01 2017-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember isgn:CustomerThreeMember 2017-01-01 2017-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember 2017-01-01 2017-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember isgn:CustomerFiveMember 2017-01-01 2017-09-30 0000727634 us-gaap:ResearchAndDevelopmentExpenseMember 2017-01-01 2017-09-30 0000727634 us-gaap:SellingAndMarketingExpenseMember 2017-01-01 2017-09-30 0000727634 us-gaap:GeneralAndAdministrativeExpenseMember 2017-01-01 2017-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember isgn:CustomerOneMember 2017-01-01 2017-09-30 0000727634 isgn:DirectorOptionsMember 2017-01-01 2017-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember isgn:CustomerSixMember 2017-01-01 2017-09-30 0000727634 us-gaap:SalesRevenueServicesNetMember isgn:CustomerSevenMember 2017-01-01 2017-09-30 0000727634 us-gaap:AccountsReceivableMember isgn:CustomerOneMember 2017-01-01 2017-09-30 0000727634 us-gaap:AccountsReceivableMember isgn:CustomerFourMember 2017-01-01 2017-09-30 0000727634 us-gaap:AccountsReceivableMember isgn:CustomerTwoMember 2017-01-01 2017-09-30 0000727634 us-gaap:AccountsReceivableMember 2017-01-01 2017-09-30 0000727634 us-gaap:AccountsReceivableMember isgn:CustomerThreeMember 2017-01-01 2017-09-30 0000727634 us-gaap:AccountsReceivableMember isgn:CustomerFiveMember 2017-01-01 2017-09-30 0000727634 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-09-30 0000727634 us-gaap:WarrantMember 2017-01-01 2017-09-30 0000727634 us-gaap:AccountsReceivableMember isgn:CustomerSixMember 2017-01-01 2017-09-30 0000727634 us-gaap:AccountsReceivableMember isgn:CustomerSevenMember 2017-01-01 2017-09-30 0000727634 us-gaap:ConvertibleNotesPayableMember 2017-01-01 2017-09-30 0000727634 isgn:RangeOneMember 2017-01-01 2017-09-30 0000727634 isgn:RangeTwoMember 2017-01-01 2017-09-30 0000727634 us-gaap:NoteWarrantMember isgn:WarrantsGroupOneMember 2017-01-01 2017-09-30 0000727634 us-gaap:NoteWarrantMember isgn:WarrantsGroupTwoMember 2017-01-01 2017-09-30 0000727634 us-gaap:NoteWarrantMember isgn:WarrantsGroupThreeMember 2017-01-01 2017-09-30 0000727634 us-gaap:NoteWarrantMember isgn:WarrantsGroupFourMember 2017-01-01 2017-09-30 0000727634 2017-09-30 0000727634 us-gaap:WarrantMember 2017-09-30 0000727634 us-gaap:TechnologyBasedIntangibleAssetsMember 2017-09-30 0000727634 us-gaap:DebtMember 2017-09-30 0000727634 isgn:RangeOneMember 2017-09-30 0000727634 isgn:RangeTwoMember 2017-09-30 0000727634 us-gaap:NoteWarrantMember isgn:WarrantsGroupOneMember 2017-09-30 0000727634 us-gaap:NoteWarrantMember isgn:WarrantsGroupTwoMember 2017-09-30 0000727634 us-gaap:NoteWarrantMember isgn:WarrantsGroupThreeMember 2017-09-30 0000727634 us-gaap:NoteWarrantMember isgn:WarrantsGroupFourMember 2017-09-30 0000727634 2017-11-14 xbrli:shares iso4217:USD iso4217:USDxbrli:shares xbrli:pure iSign Solutions Inc. 0000727634 false ISGN --12-31 10-Q 2017-09-30 2017 Q3 Smaller Reporting Company 5761980

846000

140000

389000

164000

137000

83000

56000

30000

582000

277000

20000

12000

269000

27000

17000

888000

333000

1368000

1295000

257000

200000

505000

622000

258000

377000

4000

2392000

2498000

707000

1284000

315000

210000

9000

7000

13000

7000

3436000

4006000

58000

325000

128884000

128983000

-130615000

-131839000

-14000

-2012000

-3137000

-536000

-2548000

-3673000

888000

333000

63000

0.01

20000000

5762000

5000

50000

273000

65000

157000

171000

580000

165000

498000

221000

853000

230000

655000

12000

66000

4000

11000

77000

294000

23000

92000

282000

968000

299000

884000

52000

381000

28000

136000

368000

1709000

241000

920000

791000

3418000

595000

2043000

-570000

-2565000

-365000

-1388000

1000

-11000

-5000

68000

239000

10000

91000

6000

18000

9000

107000

23000

53000

2000 58000 6000 20000 15000 225000 18000 52000

156000

330000

-449000

-2727000

-423000

-1224000

115000 130000 646000

667000

-449000

-4285000

-423000

-1224000

-0.08

-1.53

-0.07

-0.21

5498

2794

5762

276000

252000

283000

72000

139000

99000

330000

75000

-54000

-307000

-26000

602000

-73000

1000

-57000

369000

109000

-115000

14000

-1270000

-967000

2000

-2000

100000

240000

700000

505000

239000

424000

200000

564000

744000

-706000

-225000

40000

9000

15000

103000

1188000

277000

204000

498000 200000 250000

1313000

245000

780000

683000 286000

<div><table style="font: 10pt/normal 'times new roman', times, serif; width: 100%; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 0px;"></td><td style="width: 0.5in;">2.</td><td><u>Concentrations</u></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/12pt 'times new roman', times, serif; margin: 0pt 0px 0pt 0.5in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The following table summarizes accounts receivable and revenue concentrations:</p><p style="font: 10pt/12pt 'times new roman', times, serif; margin: 0pt 0px 0pt 0.5in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: justify; text-indent: -10pt; padding-left: 10pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="6">Accounts Receivable <br />As of September 30,</td><td style="padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="6">Total Revenue <br />for the three months <br />ended September 30,</td><td style="padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="6">Total Revenue <br />for the nine months <br />ended September 30,</td><td style="padding-bottom: 1.5pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: justify; text-indent: -10pt; padding-left: 10pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2017</td><td style="padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2016</td><td style="padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2017</td><td style="padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2016</td><td style="padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2017</td><td style="padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2016</td><td style="padding-bottom: 1.5pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 0.5in; background-color: white;"> </td><td style="text-align: justify; text-indent: -10pt; padding-left: 10pt;">Customer #1</td><td style="width: 15px;"> </td><td style="width: 15px; text-align: left;"> </td><td style="width: 125px; text-align: right;">53</td><td style="width: 15px; text-align: left;">%</td><td style="width: 15px;"> </td><td style="width: 15px; text-align: left;"> </td><td style="width: 125px; text-align: right;">13</td><td style="width: 15px; text-align: left;">%</td><td style="width: 15px;"> </td><td style="width: 15px; text-align: left;"> </td><td style="width: 125px; text-align: right;">10</td><td style="width: 15px; text-align: left;">%</td><td style="width: 15px;"> </td><td style="width: 15px; text-align: left;"> </td><td style="width: 125px; text-align: right;">-</td><td style="width: 15px; text-align: left;"> </td><td style="width: 15px;"> </td><td style="width: 15px; text-align: left;"> </td><td style="width: 125px; text-align: right;">10</td><td style="width: 15px; text-align: left;">%</td><td style="width: 15px;"> </td><td style="width: 15px; text-align: left;"> </td><td style="width: 125px; text-align: right;">-</td><td style="width: 15px; text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="background-color: white;"> </td><td style="text-align: justify; text-indent: -10pt; padding-left: 10pt;">Customer #2</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">18</td><td style="text-align: left;">%</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="background-color: white;"> </td><td style="text-align: justify; text-indent: -10pt; padding-left: 10pt;">Customer #3</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">14</td><td style="text-align: left;">%</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">14</td><td style="text-align: left;">%</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">14</td><td style="text-align: left;">%</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">12</td><td style="text-align: left;">%</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="background-color: white;"> </td><td style="text-align: justify; text-indent: -10pt; padding-left: 10pt;">Customer #4</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">56</td><td style="text-align: left;">%</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">15</td><td style="text-align: left;">%</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">16</td><td style="text-align: left;">%</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">16</td><td style="text-align: left;">%</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">24</td><td style="text-align: left;">%</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="background-color: white;"> </td><td style="text-align: justify; text-indent: -10pt; padding-left: 10pt;">Customer #5</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">15</td><td style="text-align: left;">%</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">16</td><td style="text-align: left;">%</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">16</td><td style="text-align: left;">%</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">12</td><td style="text-align: left;">%</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="background-color: white;"> </td><td style="text-align: justify; text-indent: -10pt; padding-left: 10pt;">Customer #6</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">17</td><td style="text-align: left;">%</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="background-color: white;"> </td><td style="text-align: justify; text-indent: -10pt; padding-bottom: 4pt; padding-left: 10pt;">Customer #7</td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">25</td><td style="text-align: left; padding-bottom: 4pt;">%</td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt;"> </td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt;"> </td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt;"> </td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt;"> </td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="background-color: white;"> </td><td style="text-align: justify; text-indent: -10pt; padding-bottom: 4pt; padding-left: 10pt; font-style: italic;">Total concentration</td><td style="padding-bottom: 4pt; font-style: italic;"> </td><td style="text-align: left; font-style: italic; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; font-style: italic; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">96</td><td style="text-align: left; padding-bottom: 4pt; font-style: italic;">%</td><td style="padding-bottom: 4pt; font-style: italic;"> </td><td style="text-align: left; font-style: italic; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; font-style: italic; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">86</td><td style="text-align: left; padding-bottom: 4pt; font-style: italic;">%</td><td style="padding-bottom: 4pt; font-style: italic;"> </td><td style="text-align: left; font-style: italic; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; font-style: italic; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">54</td><td style="text-align: left; padding-bottom: 4pt; font-style: italic;">%</td><td style="padding-bottom: 4pt; font-style: italic;"> </td><td style="text-align: left; font-style: italic; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; font-style: italic; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">46</td><td style="text-align: left; padding-bottom: 4pt; font-style: italic;">%</td><td style="padding-bottom: 4pt; font-style: italic;"> </td><td style="text-align: left; font-style: italic; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; font-style: italic; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">56</td><td style="text-align: left; padding-bottom: 4pt; font-style: italic;">%</td><td style="padding-bottom: 4pt; font-style: italic;"> </td><td style="text-align: left; font-style: italic; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; font-style: italic; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">48</td><td style="text-align: left; padding-bottom: 4pt; font-style: italic;">%</td></tr></table></div>

<table style="font: 10pt/normal 'times new roman', times, serif; width: 100%; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0px;"></td> <td style="width: 27pt;">3.</td> <td><u>Intangible Assets</u></td> </tr> </table> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt; text-align: justify; text-indent: -27pt;"> </p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27.35pt; text-align: justify;">The Company performs an intangible asset impairment analysis at least annually or whenever circumstances or events indicate such assets might be impaired. The Company would recognize an impairment charge in the event the net book value of such assets exceeded the future undiscounted cash flows attributable to such assets.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt; text-align: justify; text-indent: -27pt;"> </p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27.35pt; text-align: justify;">Management completed an analysis of the Company’s intangible assets as of December 31, 2016. Based on that analysis, the Company concluded that no impairment of the carrying value of the intangible assets existed. The Company believes that no events or circumstances changed during the three and nine months ended September 30, 2017 that would impact this conclusion.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px;"> </p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27.35pt; text-align: justify;">Amortization of intangible asset costs was $81 and $242 for the three and nine-month periods ended September 30, 2017 and $81 and $242 for the three and nine-month periods ended September 30, 2016.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px; text-indent: 27pt;"><i> </i></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px; text-indent: 27pt;">The following table summarizes the intangible assets:</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px; text-indent: 27pt;"> </p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="10">September 30, 2017</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="10">December 31, 2016</td> <td style="padding-bottom: 1.5pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Carrying Amount</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Accumulated Amortization</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Net Value</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Carrying Amount</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="border-bottom: 1.5pt solid black;" colspan="2">Accumulated Amortization</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Net Value</td> <td style="padding-bottom: 1.5pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td style="text-align: left;">Amortizable intangible assets</td> <td> </td> <td style="text-align: right;" colspan="2"> </td> <td> </td> <td> </td> <td style="text-align: right;" colspan="2"> </td> <td> </td> <td> </td> <td style="text-align: right;" colspan="2"> </td> <td> </td> <td> </td> <td style="text-align: right;" colspan="2"> </td> <td> </td> <td> </td> <td style="text-align: right;" colspan="2"> </td> <td> </td> <td> </td> <td style="text-align: right;" colspan="2"> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 27.35pt; background-color: white;"> </td> <td style="padding-left: 0.125in;">Technology</td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 125px; text-align: right;">6,745</td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 125px; text-align: right;">(6,718</td> <td style="width: 15px; text-align: left;">)</td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 125px; text-align: right;">27</td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 125px; text-align: right;">6,745</td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 125px; text-align: right;">(6,476</td> <td style="width: 15px; text-align: left;">)</td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 125px; text-align: right;">269</td> <td style="width: 15px; text-align: left;"> </td> </tr> </table>

<table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0px;"></td> <td style="width: 27pt;">6.</td> <td style="text-align: justify;"><u>Equity (Deficit)</u></td> </tr> </table> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px; text-align: justify;"><b> </b></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt; text-align: justify;">Stock-based compensation expense is based on the estimated grant date fair value of the portion of stock-based payment awards that are ultimately expected to vest during the period. The grant date fair value of stock-based awards to employees and directors is calculated using the Black-Scholes-Merton valuation model.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt; text-align: justify;"> </p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt; text-align: justify;">The weighted-average fair value of stock-based compensation is based on the Black-Scholes-Merton valuation model. Forfeitures are estimated and it is assumed no dividends will be declared. The estimated fair value of stock-based compensation awards to employees is amortized using the accrual method over the vesting period of the options.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt;"> </p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt; text-align: justify;">The Company granted 502 stock options during the nine months ended September 30, 2017 at a weighted average exercise price of $0.50 per share. There were no stock options exercised during the three and nine months ended September 30, 2017.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt; text-align: justify;"> </p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt; text-align: justify;">There were no stock options granted, and no stock options exercised during the three and nine months ended September 30, 2016.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt; text-align: justify;"> </p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt; text-align: justify;">The fair value calculations for the stock options granted are based on the following assumptions:</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt; text-align: justify;"> </p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Nine Months Ended <br />September 30, 2017</td> <td style="padding-bottom: 1.5pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 27.35pt; background-color: white;"> </td> <td style="text-align: left;">Risk free interest rate</td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 156px; text-align: right;">1.56</td> <td style="width: 15px; text-align: left;">%</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="text-align: left;">Expected life (years)</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">5.3</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="background-color: white;"> </td> <td style="text-align: left;">Expected volatility</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">212.15</td> <td style="text-align: left;">%</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="text-align: left;">Expected dividends</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"><font style="font-family: 'times new roman', times, serif;">None</font></td> <td style="text-align: left;"> </td> </tr> </table> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt; text-align: justify;"> </p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt; text-align: justify;">The following table summarizes the allocation of stock-based compensation expense related to stock option grants for the three and nine-month periods ended September 30, 2017 and 2016.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt; text-align: justify;"> </p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="6">Three Months Ended September 30,</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="6">Nine Months Ended September 30,</td> <td style="padding-bottom: 1.5pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">2017</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">2016</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">2017</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">2016</td> <td style="padding-bottom: 1.5pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 27.35pt; background-color: white;"> </td> <td style="text-align: left;"> Research and development</td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 125px; text-align: right;">15</td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 125px; text-align: right;">12</td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 125px; text-align: right;">35</td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 125px; text-align: right;">46</td> <td style="width: 15px; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="text-align: left;">Sales and marketing</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">15</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="background-color: white;"> </td> <td style="text-align: left;">General and administrative</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">19</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">15</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">39</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">59</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="text-align: left; padding-bottom: 1.5pt;">Director options</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="border-bottom: 1.5pt solid black; text-align: left;"> </td> <td style="border-bottom: 1.5pt solid black; text-align: right;">10</td> <td style="padding-bottom: 1.5pt; text-align: left;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="border-bottom: 1.5pt solid black; text-align: left;"> </td> <td style="border-bottom: 1.5pt solid black; text-align: right;">5</td> <td style="padding-bottom: 1.5pt; text-align: left;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="border-bottom: 1.5pt solid black; text-align: left;"> </td> <td style="border-bottom: 1.5pt solid black; text-align: right;">25</td> <td style="padding-bottom: 1.5pt; text-align: left;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="border-bottom: 1.5pt solid black; text-align: left;"> </td> <td style="border-bottom: 1.5pt solid black; text-align: right;">19</td> <td style="padding-bottom: 1.5pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="background-color: white;"> </td> <td style="text-align: left; padding-bottom: 4pt;">Stock-based compensation expense</td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;">$</td> <td style="border-bottom: 4pt double black; text-align: right;">44</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;">$</td> <td style="border-bottom: 4pt double black; text-align: right;">32</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;">$</td> <td style="border-bottom: 4pt double black; text-align: right;">99</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;">$</td> <td style="border-bottom: 4pt double black; text-align: right;">139</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> </tr> </table> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px;"> </p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px; text-align: justify; text-indent: 27pt;">A summary of option activity under the Company’s plans as of September 30, 2017 and 2016 is as follows:</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px; text-align: justify; text-indent: 18pt;"> </p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td style="text-align: center; padding-left: 0.125in; text-indent: -0.125in;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="14">2017</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="14">2016</td> <td style="padding-bottom: 1.5pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black; padding-left: 0in;">Options</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Shares</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Weighted Average Exercise Price Per Share</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Weighted Average Remaining Contractual Term (Years)</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Aggregate Intrinsic Value</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Shares</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Weighted Average Exercise Price Per Share</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Weighted Average Remaining Contractual Term (Years)</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Aggregate Intrinsic Value</td> <td style="padding-bottom: 1.5pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 27pt; background-color: white;"> </td> <td style="padding-left: 0.125in; text-indent: -0.125in;">Outstanding at January 1,</td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 94px; text-align: right;">71</td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 94px; text-align: right;">45.21</td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 94px; text-align: right;"> <p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0pt 0px; text-align: justify;"> </p> <p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0pt 0px; text-align: justify;"></p> </td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 94px; text-align: right;">-</td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 94px; text-align: right;">82</td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 94px; text-align: right;">45.35</td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 94px; text-align: right;"> <p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0pt 0px; text-align: justify;"> </p> <p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0pt 0px;"></p> </td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 94px; text-align: right;">     -</td> <td style="width: 15px; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="padding-left: 0.125in; text-indent: -0.125in;">Granted</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">502</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;">$</td> <td style="text-align: right;">0.50</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;">$</td> <td style="text-align: right;">       -</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;">$</td> <td style="text-align: right;">-</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;">$</td> <td style="text-align: right;">-</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="background-color: white;"> </td> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in;">Forfeited or expired</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="border-bottom: 1.5pt solid black; text-align: left;"> </td> <td style="border-bottom: 1.5pt solid black; text-align: right;">(7</td> <td style="padding-bottom: 1.5pt; text-align: left;">)</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt; text-align: left;">$</td> <td style="padding-bottom: 1.5pt; text-align: right;">7.21</td> <td style="padding-bottom: 1.5pt; text-align: left;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt; text-align: left;"> </td> <td style="padding-bottom: 1.5pt; text-align: right;"> </td> <td style="padding-bottom: 1.5pt; text-align: left;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt; text-align: left;">$</td> <td style="padding-bottom: 1.5pt; text-align: right;">-</td> <td style="padding-bottom: 1.5pt; text-align: left;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="border-bottom: 1.5pt solid black; text-align: left;"> </td> <td style="border-bottom: 1.5pt solid black; text-align: right;">(11</td> <td style="padding-bottom: 1.5pt; text-align: left;">)</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt; text-align: left;">$</td> <td style="padding-bottom: 1.5pt; text-align: right;">45.66</td> <td style="padding-bottom: 1.5pt; text-align: left;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt; text-align: left;"> </td> <td style="padding-bottom: 1.5pt; text-align: right;"> </td> <td style="padding-bottom: 1.5pt; text-align: left;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt; text-align: left;">$</td> <td style="padding-bottom: 1.5pt; text-align: right;">-</td> <td style="padding-bottom: 1.5pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="padding-bottom: 4pt; padding-left: 0.125in; text-indent: -0.125in;">Outstanding at September 30</td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;"> </td> <td style="border-bottom: 4pt double black; text-align: right;">566</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;">$</td> <td style="border-bottom: 4pt double black; text-align: right;">6.02</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;"> </td> <td style="border-bottom: 4pt double black; text-align: right;">6.09</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;">$</td> <td style="border-bottom: 4pt double black; text-align: right;">-</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;"> </td> <td style="border-bottom: 4pt double black; text-align: right;">71</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;">$</td> <td style="border-bottom: 4pt double black; text-align: right;">45.30</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;"> </td> <td style="border-bottom: 4pt double black; text-align: right;">3.41</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;">$</td> <td style="border-bottom: 4pt double black; text-align: right;">-</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="background-color: white;"> </td> <td style="text-align: left; padding-bottom: 4pt; padding-left: 0.125in; text-indent: -0.125in;">Vested and expected to vest at September 30</td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;"> </td> <td style="border-bottom: 4pt double black; text-align: right;">520</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;">$</td> <td style="border-bottom: 4pt double black; text-align: right;">6.04</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;"> </td> <td style="border-bottom: 4pt double black; text-align: right;">6.04</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;">$</td> <td style="border-bottom: 4pt double black; text-align: right;">-</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;"> </td> <td style="border-bottom: 4pt double black; text-align: right;">70</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;">$</td> <td style="border-bottom: 4pt double black; text-align: right;">46.14</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;"> </td> <td style="border-bottom: 4pt double black; text-align: right;">3.36</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;">$</td> <td style="border-bottom: 4pt double black; text-align: right;">-</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="padding-bottom: 4pt; padding-left: 0.125in; text-indent: -0.125in;">Exercisable at September 30</td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;"> </td> <td style="border-bottom: 4pt double black; text-align: right;">106</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;">$</td> <td style="border-bottom: 4pt double black; text-align: right;">29.05</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;"> </td> <td style="border-bottom: 4pt double black; text-align: right;">3.92</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;">$</td> <td style="border-bottom: 4pt double black; text-align: right;">-</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;"> </td> <td style="border-bottom: 4pt double black; text-align: right;">58</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;">$</td> <td style="border-bottom: 4pt double black; text-align: right;">49.70</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;"> </td> <td style="border-bottom: 4pt double black; text-align: right;">2.95</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;">$</td> <td style="border-bottom: 4pt double black; text-align: right;">-</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> </tr> </table> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt; text-align: justify; text-indent: -27pt;"> </p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt; text-align: justify;">The following table summarizes significant ranges of outstanding and exercisable options as of September 30, 2017:</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt; text-align: justify; text-indent: -27pt;"> </p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td style="text-align: left;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="10">Options Outstanding</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="6">Options Exercisable</td> <td style="padding-bottom: 1.5pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td style="text-align: left; border-bottom: 1.5pt solid black;">Range of Exercise Prices</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Number Outstanding</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Weighted Average Remaining Contractual Life (in years)</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Weighted Average Exercise Price Per Share</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Number Outstanding</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Weighted Average Exercise Price Per Share</td> <td style="padding-bottom: 1.5pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 27pt; background-color: white;"> </td> <td style="text-align: left;">$0.01 – $25.00</td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 125px; text-align: right;">498</td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 125px; text-align: right;">6.60</td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 125px; text-align: right;">0.56</td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 125px; text-align: right;">42</td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 125px; text-align: right;">1.02</td> <td style="width: 15px; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="text-align: left; padding-bottom: 1.5pt;">$25.01 - $625.00</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="border-bottom: 1.5pt solid black; text-align: left;"> </td> <td style="border-bottom: 1.5pt solid black; text-align: right;">68</td> <td style="padding-bottom: 1.5pt; text-align: left;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt; text-align: left;"> </td> <td style="padding-bottom: 1.5pt; text-align: right;">2.33</td> <td style="padding-bottom: 1.5pt; text-align: left;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt; text-align: left;">$</td> <td style="padding-bottom: 1.5pt; text-align: right;">46.17</td> <td style="padding-bottom: 1.5pt; text-align: left;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="border-bottom: 1.5pt solid black; text-align: left;"> </td> <td style="border-bottom: 1.5pt solid black; text-align: right;">64</td> <td style="padding-bottom: 1.5pt; text-align: left;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt; text-align: left;">$</td> <td style="padding-bottom: 1.5pt; text-align: right;">47.25</td> <td style="padding-bottom: 1.5pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="background-color: white;"> </td> <td style="text-align: left; padding-bottom: 4pt;">Total</td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;"> </td> <td style="border-bottom: 4pt double black; text-align: right;">566</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt; text-align: right;">6.09</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="padding-bottom: 4pt; text-align: left;">$</td> <td style="padding-bottom: 4pt; text-align: right;">6.02</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;"> </td> <td style="border-bottom: 4pt double black; text-align: right;">106</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="padding-bottom: 4pt; text-align: left;">$</td> <td style="padding-bottom: 4pt; text-align: right;">29.05</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> </tr> </table> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt; text-align: justify;"> </p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt; text-align: justify;">The following table summarizes <font style="font-family: 'times new roman', times, serif;">the Company’s non-vested option shares as of September 30, 2017:</font></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt; text-align: justify;"> </p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td style="text-align: left; border-bottom: 1.5pt solid black;">Non-vested Option Shares</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Shares</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Weighted Average <br />Grant-Date <br />Fair Value</td> <td style="padding-bottom: 1.5pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 27pt; background-color: white;"> </td> <td style="text-align: justify;">Non-vested at January 1, 2017</td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 125px; text-align: right;">11</td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 125px; text-align: right;">23.01</td> <td style="width: 15px; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="text-align: justify;">Granted</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">502</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;">$</td> <td style="text-align: right;">0.50</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="background-color: white;"> </td> <td style="text-align: justify;">Forfeited</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">(6</td> <td style="text-align: left;">)</td> <td> </td> <td style="text-align: left;">$</td> <td style="text-align: right;">0.75</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="text-align: justify; padding-bottom: 1.5pt;">Vested</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="border-bottom: 1.5pt solid black; text-align: left;"> </td> <td style="border-bottom: 1.5pt solid black; text-align: right;">(47</td> <td style="padding-bottom: 1.5pt; text-align: left;">)</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt; text-align: left;">$</td> <td style="padding-bottom: 1.5pt; text-align: right;">0.99</td> <td style="padding-bottom: 1.5pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="background-color: white;"> </td> <td style="padding-bottom: 4pt;">Non-vested at September 30, 2017</td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;"> </td> <td style="border-bottom: 4pt double black; text-align: right;">460</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="padding-bottom: 4pt; text-align: left;">$</td> <td style="padding-bottom: 4pt; text-align: right;">0.76</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> </tr> </table> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt; text-align: justify;"> </p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt; text-align: justify;">As of September 30, 2017, there was $101 of total unrecognized compensation expense related to non-vested stock-based compensation arrangements granted under the plans. The unrecognized compensation expense is expected to be realized over a weighted average period of 2.1 years.</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt;"> </p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt;"><u>Warrants</u></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt;"> </p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt;">A summary of the warrant activity for the nine months ended September 30 is as follows:</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt;"> </p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="6">September 30, 2017</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="6">September 30, 2016</td> <td style="padding-bottom: 1.5pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Shares</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Weighted Average Exercise Price Per Share</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Shares</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Weighted Average Exercise Price Per Share</td> <td style="padding-bottom: 1.5pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 27pt; background-color: white;"> </td> <td>Outstanding at beginning of period</td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 125px; text-align: right;">1,882</td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 125px; text-align: right;">2.52</td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 125px; text-align: right;">205</td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 125px; text-align: right;">35.51</td> <td style="width: 15px; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td>Issued</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;">$</td> <td style="text-align: right;">-</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">1,551</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;">$</td> <td style="text-align: right;">2.18</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="background-color: white;"> </td> <td style="padding-bottom: 1.5pt;">Expired</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="border-bottom: 1.5pt solid black; text-align: left;"> </td> <td style="border-bottom: 1.5pt solid black; text-align: right;">(4</td> <td style="padding-bottom: 1.5pt; text-align: left;">)</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="border-bottom: 1.5pt solid black; text-align: left;">$</td> <td style="border-bottom: 1.5pt solid black; text-align: right;">34.38</td> <td style="padding-bottom: 1.5pt; text-align: left;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="border-bottom: 1.5pt solid black; text-align: left;"> </td> <td style="border-bottom: 1.5pt solid black; text-align: right;">-</td> <td style="padding-bottom: 1.5pt; text-align: left;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="border-bottom: 1.5pt solid black; text-align: left;">$</td> <td style="border-bottom: 1.5pt solid black; text-align: right;">-</td> <td style="padding-bottom: 1.5pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td style="padding-bottom: 4pt;">Outstanding at end of period</td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;"> </td> <td style="border-bottom: 4pt double black; text-align: right;">1,878</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;">$</td> <td style="border-bottom: 4pt double black; text-align: right;">1.53</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;"> </td> <td style="border-bottom: 4pt double black; text-align: right;">1,756</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;">$</td> <td style="border-bottom: 4pt double black; text-align: right;">5.27</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="background-color: white;"> </td> <td style="padding-bottom: 4pt;">Exercisable at end of period</td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;"> </td> <td style="border-bottom: 4pt double black; text-align: right;">1,878</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;">$</td> <td style="border-bottom: 4pt double black; text-align: right;">1.53</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;"> </td> <td style="border-bottom: 4pt double black; text-align: right;">1,756</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;">$</td> <td style="border-bottom: 4pt double black; text-align: right;">5.27</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="background-color: white;"> </td> <td> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> </tr> </table> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt;"> </p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt;">A summary of the status of the warrants outstanding and exercisable as of September 30, 2017 is as follows:</p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt;"> </p> <table align="center" style="font: 10pt/normal 'times new roman', times, serif; width: 1253px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap" style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Number of shares exercisable<br />under Warrants</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt;"> </td> <td nowrap="nowrap" style="padding-bottom: 1.5pt;"> </td> <td nowrap="nowrap" style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Weighted Average<br />Remaining Life Years</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt;"> </td> <td nowrap="nowrap" style="padding-bottom: 1.5pt;"> </td> <td nowrap="nowrap" style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Weighted Average Exercise<br />Price per share</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 13px; text-align: left;"> </td> <td style="width: 389px; text-align: right;">50</td> <td style="width: 13px; text-align: left;"> </td> <td style="width: 13px;"> </td> <td style="width: 13px; text-align: left;"> </td> <td style="width: 389px; text-align: right;">0.01</td> <td style="width: 12px; text-align: left;"> </td> <td style="width: 12px;"> </td> <td style="width: 12px; text-align: left;">$</td> <td style="width: 375px; text-align: right;">0.42</td> <td style="width: 12px; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;"> </td> <td style="text-align: right;">277</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">0.42</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;">$</td> <td style="text-align: right;">0.24</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="border-bottom: 4pt double black; text-align: left;"> </td> <td style="border-bottom: 4pt double black; text-align: right;">1,551</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;"> </td> <td style="border-bottom: 4pt double black; text-align: right;">3.04</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;">$</td> <td style="border-bottom: 4pt double black; text-align: right;">1.80</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="border-bottom: 4pt double black; text-align: left;"> </td> <td style="border-bottom: 4pt double black; text-align: right;">1,878</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;"> </td> <td style="border-bottom: 4pt double black; text-align: right;">2.57</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;">$</td> <td style="border-bottom: 4pt double black; text-align: right;">1.53</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> </tr> </table> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 36pt; text-align: justify;"> </p>

<div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.5in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><u>Basis of Presentation</u></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.25in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/12pt 'times new roman', times, serif; margin: 0pt 0px 0pt 0.5in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The financial information contained herein should be read in conjunction with the Company's consolidated audited financial statements and notes thereto included in its Annual Report on Form 10-K for the year ended December 31, 2016.</p><p style="font: 10pt/12pt 'times new roman', times, serif; margin: 0pt 0px 0pt 0.5in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/12pt 'times new roman', times, serif; margin: 0pt 0px 0pt 0.5in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The accompanying unaudited condensed consolidated financial statements of the Company have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America (“GAAP”) for complete consolidated financial statements. In the opinion of management, the unaudited condensed consolidated financial statements included in this quarterly report reflect all adjustments (consisting only of normal recurring adjustments) that the Company considers necessary for a fair presentation of its financial position at the dates presented and the Company’s results of operations and cash flows for the periods presented. The Company’s interim results are not necessarily indicative of the results to be expected for the entire year.</p></div>

<div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.5in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><i>Going Concern</i></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.5in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/12pt 'times new roman', times, serif; margin: 0pt 0px 0pt 0.5in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The accompanying unaudited condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has incurred significant cumulative losses since its inception and, at September 30, 2017, the Company’s accumulated deficit was $131,839. The Company has primarily met its working capital needs through the sale of debt and equity securities. As of September 30, 2017, the Company’s cash balance was $164. These factors raise substantial doubt about the Company’s ability to continue as a going concern.</p><p style="font: 10pt/12pt 'times new roman', times, serif; margin: 0pt 0px 0pt 0.5in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.5in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">There can be no assurance that the Company will be successful in securing adequate capital resources to fund planned operations or that any additional funds will be available to the Company when needed, or if available, will be available on favorable terms or in amounts required by the Company. If the Company is unable to obtain adequate capital resources to fund operations, it may be required to delay, scale back or eliminate some or all of its operations, which may have a material adverse effect on the Company's business, results of operations and ability to operate as a going concern. The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p></div>

<div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.5in; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><i>Accounting Changes and Recent Accounting Pronouncements</i></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.5in; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.5in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In May 2017, the Financial Accounting Standards Board (“FASB”) issued ASU 2017-09, <i>Compensation (Subtopic 718-20): Stock Compensation - Scope of Modification Accounting</i>. ASU 2017-09 provides guidance on determining which changes to the terms and conditions of share-based payment awards require an entity to apply modification accounting under Topic 718. The guidance is effective for annual periods after December 15, 2017. Implementation of ASU 2017-09 is not expected to have a material impact on the Company’s financial position, results of operations and cash flows.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.5in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.5in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In July 2017, the FASB issued ASU 2017-11, Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Non-controlling Interests with a Scope Exception. ASU 2017-11 addresses the narrow issues identified as a result of the complexity associated with applying generally accepted accounting principles (GAAP) for certain financial instruments with characteristics of liabilities and equity in two parts, (1) Addressing financial instruments with down round features, and (2) which relates to non-public entities. For public business entities, the amendments in Part I of this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.5in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.5in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities. ASU 2017-12 has been issued with the objective of improving the financial reporting of hedging relationships to better portray the economic results of an entity’s risk management activities in its financial statements. In addition to that main objective, the amendments in this Update make certain targeted improvements to simplify the application of the hedge accounting guidance in current GAAP based on the feedback received from preparers, auditors, users, and other stakeholders. For public business entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.5in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.5in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In September 2017, the FASB issued ASU 2017-13, Revenue Recognition (Topic 605), Revenue from Contracts with Customers (Topic 606), Leases (Topic 840), and Leases (Topic 842). ASU 2017-13 adds SEC paragraphs pursuant to an SEC Staff Announcement made at the July 20, 2017 Emerging Issues Task Force (EITF) meeting.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.5in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 0.5in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Implementation of the above ASU’s issued in 2017 are not expected to have a material impact on the Company’s financial position, results of operations and cash flows.</p></div>

<div><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: justify; text-indent: -10pt; padding-left: 10pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="6">Accounts Receivable <br />As of September 30,</td><td style="padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="6">Total Revenue <br />for the three months <br />ended September 30,</td><td style="padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="6">Total Revenue <br />for the nine months <br />ended September 30,</td><td style="padding-bottom: 1.5pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: justify; text-indent: -10pt; padding-left: 10pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2017</td><td style="padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2016</td><td style="padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2017</td><td style="padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2016</td><td style="padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2017</td><td style="padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2016</td><td style="padding-bottom: 1.5pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 0.5in; background-color: white;"> </td><td style="text-align: justify; text-indent: -10pt; padding-left: 10pt;">Customer #1</td><td style="width: 15px;"> </td><td style="width: 15px; text-align: left;"> </td><td style="width: 125px; text-align: right;">53</td><td style="width: 15px; text-align: left;">%</td><td style="width: 15px;"> </td><td style="width: 15px; text-align: left;"> </td><td style="width: 125px; text-align: right;">13</td><td style="width: 15px; text-align: left;">%</td><td style="width: 15px;"> </td><td style="width: 15px; text-align: left;"> </td><td style="width: 125px; text-align: right;">10</td><td style="width: 15px; text-align: left;">%</td><td style="width: 15px;"> </td><td style="width: 15px; text-align: left;"> </td><td style="width: 125px; text-align: right;">-</td><td style="width: 15px; text-align: left;"> </td><td style="width: 15px;"> </td><td style="width: 15px; text-align: left;"> </td><td style="width: 125px; text-align: right;">10</td><td style="width: 15px; text-align: left;">%</td><td style="width: 15px;"> </td><td style="width: 15px; text-align: left;"> </td><td style="width: 125px; text-align: right;">-</td><td style="width: 15px; text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="background-color: white;"> </td><td style="text-align: justify; text-indent: -10pt; padding-left: 10pt;">Customer #2</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">18</td><td style="text-align: left;">%</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="background-color: white;"> </td><td style="text-align: justify; text-indent: -10pt; padding-left: 10pt;">Customer #3</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">14</td><td style="text-align: left;">%</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">14</td><td style="text-align: left;">%</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">14</td><td style="text-align: left;">%</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">12</td><td style="text-align: left;">%</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="background-color: white;"> </td><td style="text-align: justify; text-indent: -10pt; padding-left: 10pt;">Customer #4</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">56</td><td style="text-align: left;">%</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">15</td><td style="text-align: left;">%</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">16</td><td style="text-align: left;">%</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">16</td><td style="text-align: left;">%</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">24</td><td style="text-align: left;">%</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="background-color: white;"> </td><td style="text-align: justify; text-indent: -10pt; padding-left: 10pt;">Customer #5</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">15</td><td style="text-align: left;">%</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">16</td><td style="text-align: left;">%</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">16</td><td style="text-align: left;">%</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">12</td><td style="text-align: left;">%</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="background-color: white;"> </td><td style="text-align: justify; text-indent: -10pt; padding-left: 10pt;">Customer #6</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">17</td><td style="text-align: left;">%</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="background-color: white;"> </td><td style="text-align: justify; text-indent: -10pt; padding-bottom: 4pt; padding-left: 10pt;">Customer #7</td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">25</td><td style="text-align: left; padding-bottom: 4pt;">%</td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt;"> </td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt;"> </td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt;"> </td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt;"> </td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="background-color: white;"> </td><td style="text-align: justify; text-indent: -10pt; padding-bottom: 4pt; padding-left: 10pt; font-style: italic;">Total concentration</td><td style="padding-bottom: 4pt; font-style: italic;"> </td><td style="text-align: left; font-style: italic; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; font-style: italic; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">96</td><td style="text-align: left; padding-bottom: 4pt; font-style: italic;">%</td><td style="padding-bottom: 4pt; font-style: italic;"> </td><td style="text-align: left; font-style: italic; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; font-style: italic; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">86</td><td style="text-align: left; padding-bottom: 4pt; font-style: italic;">%</td><td style="padding-bottom: 4pt; font-style: italic;"> </td><td style="text-align: left; font-style: italic; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; font-style: italic; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">54</td><td style="text-align: left; padding-bottom: 4pt; font-style: italic;">%</td><td style="padding-bottom: 4pt; font-style: italic;"> </td><td style="text-align: left; font-style: italic; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; font-style: italic; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">46</td><td style="text-align: left; padding-bottom: 4pt; font-style: italic;">%</td><td style="padding-bottom: 4pt; font-style: italic;"> </td><td style="text-align: left; font-style: italic; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; font-style: italic; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">56</td><td style="text-align: left; padding-bottom: 4pt; font-style: italic;">%</td><td style="padding-bottom: 4pt; font-style: italic;"> </td><td style="text-align: left; font-style: italic; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; font-style: italic; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">48</td><td style="text-align: left; padding-bottom: 4pt; font-style: italic;">%</td></tr></table></div>

<p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px; text-indent: 27pt;"></p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="10">September 30, 2017</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="10">December 31, 2016</td> <td style="padding-bottom: 1.5pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Carrying Amount</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Accumulated Amortization</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Net Value</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Carrying Amount</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="border-bottom: 1.5pt solid black;" colspan="2">Accumulated Amortization</td> <td style="padding-bottom: 1.5pt;"> </td> <td style="padding-bottom: 1.5pt;"> </td> <td style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Net Value</td> <td style="padding-bottom: 1.5pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="background-color: white;"> </td> <td style="text-align: left;">Amortizable intangible assets</td> <td> </td> <td style="text-align: right;" colspan="2"> </td> <td> </td> <td> </td> <td style="text-align: right;" colspan="2"> </td> <td> </td> <td> </td> <td style="text-align: right;" colspan="2"> </td> <td> </td> <td> </td> <td style="text-align: right;" colspan="2"> </td> <td> </td> <td> </td> <td style="text-align: right;" colspan="2"> </td> <td> </td> <td> </td> <td style="text-align: right;" colspan="2"> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 27.35pt; background-color: white;"> </td> <td style="padding-left: 0.125in;">Technology</td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 125px; text-align: right;">6,745</td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 125px; text-align: right;">(6,718</td> <td style="width: 15px; text-align: left;">)</td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 125px; text-align: right;">27</td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 125px; text-align: right;">6,745</td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 125px; text-align: right;">(6,476</td> <td style="width: 15px; text-align: left;">)</td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 125px; text-align: right;">269</td> <td style="width: 15px; text-align: left;"> </td> </tr> </table> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px;"> </p>

<div><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: center; text-indent: -10pt; padding-bottom: 1.5pt; padding-left: 10pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="14">2017</td><td style="padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="14">2016</td><td style="padding-bottom: 1.5pt;"> </td></tr><tr style="vertical-align: bottom;"><td style="background-color: white;"> </td><td style="text-align: center; text-indent: 0px; padding-left: 0px; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 17.1pt; text-align: center; text-indent: -4.5pt; font-stretch: normal;"> </p><p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; text-indent: 0px; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0px; font-stretch: normal;">Options</p></td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: center; font-stretch: normal;">Shares</p></td><td style="padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Weighted Average Exercise Price Per Share</font></td><td style="padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Weighted Average Remaining Contractual Term (Years)</font></td><td style="padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: center; font-stretch: normal;">Aggregate Intrinsic Value</p></td><td style="padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: center; font-stretch: normal;">Shares</p></td><td style="padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Weighted Average Exercise Price Per Share</font></td><td style="padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">Weighted Average Remaining Contractual Term (Years)</font></td><td style="padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: center; font-stretch: normal;">Aggregate Intrinsic Value</p></td><td style="padding-bottom: 1.5pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 0.5in; background-color: white;"> </td><td style="text-indent: -10pt; padding-left: 10pt;">Outstanding at January 1,</td><td style="width: 7px;"> </td><td style="width: 7px; text-align: left;"> </td><td style="width: 109px; text-align: right;">71</td><td style="width: 7px; text-align: left;"> </td><td style="width: 7px;"> </td><td style="width: 7px; text-align: left;">$</td><td style="width: 109px; text-align: right;">45.21</td><td style="width: 7px; text-align: left;"> </td><td style="width: 7px;"> </td><td style="width: 7px; text-align: left;"> </td><td style="width: 109px; text-align: right;"> </td><td style="width: 7px; text-align: left;"> </td><td style="width: 7px;"> </td><td style="width: 7px; text-align: left;">$</td><td style="width: 109px; text-align: right;">             -</td><td style="width: 7px; text-align: left;"> </td><td style="width: 7px;"> </td><td style="width: 7px; text-align: left;"> </td><td style="width: 109px; text-align: right;">82</td><td style="width: 7px; text-align: left;"> </td><td style="width: 7px;"> </td><td style="width: 7px; text-align: left;">$</td><td style="width: 109px; text-align: right;">45.35</td><td style="width: 7px; text-align: left;"> </td><td style="width: 7px;"> </td><td style="width: 7px; text-align: left;"> </td><td style="width: 109px; text-align: right;"> </td><td style="width: 7px; text-align: left;"> </td><td style="width: 7px;"> </td><td style="width: 7px; text-align: left;">$</td><td style="width: 109px; text-align: right;">             -</td><td style="width: 7px; text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="background-color: white;"> </td><td style="text-indent: -10pt; padding-left: 10pt;">Granted</td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">502</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;">$</td><td style="text-align: right;">0.50</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;"> </td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;">$</td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;">$</td><td style="text-align: right;">-</td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;"> </td><td style="text-align: right;"> </td><td style="text-align: left;"> </td><td> </td><td style="text-align: left;">$</td><td style="text-align: right;">-</td><td style="text-align: left;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="background-color: white;"> </td><td style="text-align: left; text-indent: -10pt; padding-bottom: 1.5pt; padding-left: 10pt;">Forfeited or expired</td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">(7</td><td style="text-align: left; padding-bottom: 1.5pt;">)</td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: left; padding-bottom: 1.5pt;">$</td><td style="text-align: right; padding-bottom: 1.5pt;">7.21</td><td style="text-align: left; padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: left; padding-bottom: 1.5pt;"> </td><td style="text-align: right; padding-bottom: 1.5pt;"> </td><td style="text-align: left; padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: left; padding-bottom: 1.5pt;">$</td><td style="text-align: right; padding-bottom: 1.5pt;">-</td><td style="text-align: left; padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"> </td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">(11</td><td style="text-align: left; padding-bottom: 1.5pt;">)</td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: left; padding-bottom: 1.5pt;">$</td><td style="text-align: right; padding-bottom: 1.5pt;">45.66</td><td style="text-align: left; padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: left; padding-bottom: 1.5pt;"> </td><td style="text-align: right; padding-bottom: 1.5pt;"> </td><td style="text-align: left; padding-bottom: 1.5pt;"> </td><td style="padding-bottom: 1.5pt;"> </td><td style="text-align: left; padding-bottom: 1.5pt;">$</td><td style="text-align: right; padding-bottom: 1.5pt;">-</td><td style="text-align: left; padding-bottom: 1.5pt;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="background-color: white;"> </td><td style="text-indent: -10pt; padding-bottom: 4pt; padding-left: 10pt;">Outstanding at September 30</td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">566</td><td style="text-align: left; padding-bottom: 4pt;"> </td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">6.02</td><td style="text-align: left; padding-bottom: 4pt;"> </td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">6.09</td><td style="text-align: left; padding-bottom: 4pt;"> </td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt;"> </td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">71</td><td style="text-align: left; padding-bottom: 4pt;"> </td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">45.30</td><td style="text-align: left; padding-bottom: 4pt;"> </td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">3.41</td><td style="text-align: left; padding-bottom: 4pt;"> </td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt;"> </td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="background-color: white;"> </td><td style="text-align: left; text-indent: -10pt; padding-bottom: 4pt; padding-left: 10pt;">Vested and expected to vest at September 30</td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">520</td><td style="text-align: left; padding-bottom: 4pt;"> </td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">6.04</td><td style="text-align: left; padding-bottom: 4pt;"> </td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">6.04</td><td style="text-align: left; padding-bottom: 4pt;"> </td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt;"> </td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">70</td><td style="text-align: left; padding-bottom: 4pt;"> </td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">46.14</td><td style="text-align: left; padding-bottom: 4pt;"> </td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">3.36</td><td style="text-align: left; padding-bottom: 4pt;"> </td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt;"> </td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="background-color: white;"> </td><td style="text-indent: -10pt; padding-bottom: 4pt; padding-left: 10pt;">Exercisable at September 30</td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">106</td><td style="text-align: left; padding-bottom: 4pt;"> </td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">29.05</td><td style="text-align: left; padding-bottom: 4pt;"> </td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">3.92</td><td style="text-align: left; padding-bottom: 4pt;"> </td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt;"> </td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">58</td><td style="text-align: left; padding-bottom: 4pt;"> </td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">49.70</td><td style="text-align: left; padding-bottom: 4pt;"> </td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"> </td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">2.95</td><td style="text-align: left; padding-bottom: 4pt;"> </td><td style="padding-bottom: 4pt;"> </td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">-</td><td style="text-align: left; padding-bottom: 4pt;"> </td></tr></table></div>

<p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-stretch: normal; line-height: normal; margin: 0pt 0px 0pt 27pt;"></p> <table align="center" style="font: 10pt/normal 'times new roman', times, serif; width: 1253px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap" style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Number of shares exercisable<br />under Warrants</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt;"> </td> <td nowrap="nowrap" style="padding-bottom: 1.5pt;"> </td> <td nowrap="nowrap" style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Weighted Average<br />Remaining Life Years</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt;"> </td> <td nowrap="nowrap" style="padding-bottom: 1.5pt;"> </td> <td nowrap="nowrap" style="text-align: center; border-bottom: 1.5pt solid black;" colspan="2">Weighted Average Exercise<br />Price per share</td> <td nowrap="nowrap" style="padding-bottom: 1.5pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 13px; text-align: left;"> </td> <td style="width: 389px; text-align: right;">50</td> <td style="width: 13px; text-align: left;"> </td> <td style="width: 13px;"> </td> <td style="width: 13px; text-align: left;"> </td> <td style="width: 389px; text-align: right;">0.01</td> <td style="width: 12px; text-align: left;"> </td> <td style="width: 12px;"> </td> <td style="width: 12px; text-align: left;">$</td> <td style="width: 375px; text-align: right;">0.42</td> <td style="width: 12px; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;"> </td> <td style="text-align: right;">277</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">0.42</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;">$</td> <td style="text-align: right;">0.24</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="border-bottom: 4pt double black; text-align: left;"> </td> <td style="border-bottom: 4pt double black; text-align: right;">1,551</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;"> </td> <td style="border-bottom: 4pt double black; text-align: right;">3.04</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;">$</td> <td style="border-bottom: 4pt double black; text-align: right;">1.80</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="border-bottom: 4pt double black; text-align: left;"> </td> <td style="border-bottom: 4pt double black; text-align: right;">1,878</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;"> </td> <td style="border-bottom: 4pt double black; text-align: right;">2.57</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> <td style="padding-bottom: 4pt;"> </td> <td style="border-bottom: 4pt double black; text-align: left;">$</td> <td style="border-bottom: 4pt double black; text-align: right;">1.53</td> <td style="padding-bottom: 4pt; text-align: left;"> </td> </tr> </table>

0.16

0.14

0.46

0.16

0.24

0.12

0.48

0.12

0.13

0.56

0.86

0.17

0.15

0.14

0.54

0.15

0.10

0.16

0.14

0.56

0.16

0.10

0.53

0.18

0.96

0.25

6745000

6476000

6718000

81000

242000

81000

242000

71000

1756000

566000

1878000

120000

6000

The Company would repay the advance to the lenders on a pro rata basis together with a 5% advance fee.

1.30

0.50

1000000

0.06

0.10

2018-12-31

24000

72000

277 200000 200000

Should the secured notes remain outstanding following the maturity date an additional 30% of the note's principal amount shall become due and payable.

250000

0.0156

P5Y3M19D

2.1215

32000

12000

15000

5000

139000

46000

15000

59000

19000

44000

15000

19000

10000

99000

35000

39000

25000

82000

71000

566000

502000

11000

7000

70000

520000

58000

106000

45.35

45.30

45.21

6.02

0.50

45.66

7.21

46.14

6.04

49.70

29.05

P3Y4M28D

P6Y1M2D

P3Y4M9D

P6Y0M15D

P2Y11M12D

P3Y11M1D

0.01

25.01

25.00

625.00

566

498

P6Y1M2D

P6Y7M6D

P2Y3M29D

6.02

0.56

46.17

106

29.05

1.02

47.25

11000 460000 502000 6000 47000 23.01 0.76 0.50 0.75 0.99

205000

1756000

1882000

1878000

50000

277000

1551000

1878000

1551000 -4000 1756000 1878000

35.51

5.27

2.52

1.53

2.18 34.38 5.27 1.53 P0Y0M4D P0Y5M1D P3Y0M15D P2Y6M25D 0.42 0.24 1.80 1.53

502000

0.50

101000

P2Y1M6D

EX-101.SCH 7 isgn-20170930.xsd XBRL SCHEMA FILE 001 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Nature of Business and Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Concentrations link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Intangible Assets link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Net Loss Per Share link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Debt link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Equity (Deficit) link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Nature of Business and Summary of Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Concentrations (Tables) link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Intangible Assets (Tables) link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Net Loss Per Share (Tables) link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Equity (Deficit) (Tables) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Nature of Business and Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Concentrations (Details) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Intangible Assets (Details) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Intangible Assets (Details Textual) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Net Loss Per Share (Details) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Debt (Details) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Equity (Deficit) (Details) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Equity (Deficit) (Details1) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Equity (Deficit) (Details 2) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Equity (Deficit) (Details 3) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Equity (Deficit) (Details 4) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Equity (Deficit) (Details 5) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Equity (Deficit) (Details 6) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Equity (Deficit) (Details Textual) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 isgn-20170930_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 isgn-20170930_def.xml XBRL DEFINITION FILE EX-101.LAB 10 isgn-20170930_lab.xml XBRL LABEL FILE Document and Entity Information [Abstract] Entity Registrant Name Entity Central Index Key Amendment Flag Trading Symbol Current Fiscal Year End Date Document Type Document Period End Date Document Fiscal Year Focus Document Fiscal Period Focus Entity Filer Category Entity Common Stock, Shares Outstanding Statement of Financial Position [Abstract] Statement [Table] Statement [Line Items] Statement Assets [Abstract] Assets Assets, Current [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Cash balance Accounts Receivable, Net, Current Accounts receivable, net of allowance of $0 at September 30, 2017 and $63 at December 31, 2016, respectively Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Assets, Current Total current assets Property, Plant and Equipment, Net Property and equipment, net Property and equipment Finite-Lived Intangible Assets, Net Finite-lived intangible assets, net Intangible assets, net Net Value Other Assets, Noncurrent Other assets Assets Total assets Liabilities and Stockholders' Equity [Abstract] Liabilities and Deficit Liabilities, Current [Abstract] Current liabilities: Accounts Payable, Current Accounts payable Accrued Salaries, Current Accrued compensation Other Accrued Liabilities, Current Other Other accrued liabilities Other Deferred Revenue, Current Deferred revenue Capital Lease Obligations, Current Short-term capital lease Liabilities, Current Total current liabilities Long-term Debt Long-term debt, net Deferred Revenue, Noncurrent Deferred revenue long-term Capital Lease Obligations, Noncurrent Long-term capital lease Other Liabilities, Noncurrent Other long-term liabilities Liabilities Total liabilities Commitments and Contingencies. Commitments and contingencies Stockholders' Equity Attributable to Parent [Abstract] Deficit: Common Stock, Value, Issued Common stock, $0.01 par value; 20,000 shares authorized; 5,762 shares issued and outstanding at September 30, 2017 and December 31, 2016 Common stock Treasury Stock, Value Treasury stock Treasury shares, 5 at September 30, 2017 and December 31, 2016 Additional Paid in Capital Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive loss Stockholders' Equity Attributable to Parent Total iSign stockholders' deficit Stockholders' Equity Attributable to Noncontrolling Interest Non-controlling interest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Total deficit Beginning balance Ending balance Liabilities and Stockholders' Equity Total liabilities and deficit Allowance for Doubtful Accounts Receivable, Current Accounts receivable, allowance Accounts receivable, net of allowance Common Stock, Par or Stated Value Per Share Common stock, par value Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding Treasury Stock, Shares Consolidated Statements of Operations (Unaudited) Revenues [Abstract] Revenue: Sales Revenue, Goods, Net Product Maintenance Revenue Maintenance Revenues Total revenues Total revenue Costs and Expenses [Abstract] Operating costs and expenses Operating costs and expenses: Cost of Revenue [Abstract] Cost of sales: Cost of Goods Sold, Direct Materials Product Cost of Goods Sold, Maintenance Costs Maintenance Research and Development Expense Research and development Selling and Marketing Expense Sales and marketing General and Administrative Expense General and administrative Costs and Expenses Total operating costs and expenses Operating Income (Loss) Loss from operations Other Nonoperating Income (Expense) Other income (expense), net Gain (Loss) on Disposition of Intangible Assets Gain on sale of intangible asset Gain on sale of intangible asset Interest Expense [Abstract] Interest expense: Interest Expense, Related Party Related party Interest Expense, Other Other Amortization of Financing Costs and Discounts [Abstract] Amortization of debt discount: Amortization Of Financing Costs And Discounts Related Party Amortization of financing costs and discounts related party. Related party Amortization Of Financing Costs And Discounts Other Amortization of financing costs and discounts other. Other Gain (Loss) on Derivative Instruments, Net, Pretax Gain on derivative liability Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Net loss Net loss Accretion Of Beneficial Conversion Feature Preferred Stock [Abstract] Accretion of beneficial conversion feature: Preferred Stock: Accretion Of Beneficial Conversion Feature Preferred Stock Related Party Related party Amount of accretion of beneficial conversion feature preferred stock related party. Related party Accretion Of Beneficial Conversion Feature Preferred Stock Other Other Amount of accretion of beneficial conversion feature preferred stock other. Other Preferred Stock Dividends and Other Adjustments [Abstract] Preferred stock dividends: Preferred stock dividends: Preferred Stock Dividends, Related Party Preferred stock dividends, related party The aggregate value of preferred stock dividends related party necessary to derive net income apportioned to common stockholders. Related party Preferred Stock Dividends and Other Adjustments Related party (Note 9) Accretion of Beneficial Conversion Feature on Preferred Shares Other Net Income (Loss) Attributable to Parent Net loss Numerator - basic and diluted net loss Net loss Net loss attributable to common stockholders Earnings Per Share, Basic and Diluted Net loss per share - bacis and diluted Basic and diluted loss per common share Basic and diluted loss per common share Basic and diluted net loss per common share Weighted Average Number of Shares Outstanding, Basic and Diluted Denominator-basic or diluted weighted average number of common shares outstanding Weighted average common shares outstanding, basic and diluted Statement of Cash Flows [Abstract] Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Cash flows from operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Depreciation, Depletion and Amortization Depreciation and amortization Depreciation and amortization Amortization of Debt Discount (Premium) Debt discount amortization Share-based Compensation Stock-based employee compensation Stock-based compensation Stock-based employee compensation Unrealized Gain (Loss) on Derivatives Gain on derivative liability Net gain on derivative liability Gain on derivative liability Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Accounts Receivable Accounts receivable, net Accounts receivable Increase (Decrease) in Prepaid, Deferred Expense and Other Assets Prepaid expenses and other assets Prepaid expenses and other assets Increase (Decrease) in Accounts Payable Accounts payable Accounts payable Increase (Decrease) in Accrued Salaries Accrued compensation Accrued Compensation Increase (Decrease) in Other Accrued Liabilities Other accrued and long-term liabilities Other accrued and long-term liabilities Increase (Decrease) in Deferred Revenue Deferred revenue Deferred revenue Net Cash Provided by (Used in) Operating Activities, Continuing Operations Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Cash flows from investing activities: Payments to Acquire Property, Plant, and Equipment Acquisition of property and equipment Net Cash Provided by (Used in) Investing Activities, Continuing Operations Net cash used in investing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Cash flows from financing activities: Proceeds from Short-term Debt Proceeds from issuance of short-term notes payable Proceeds from Issuance of Long-term Debt Proceeds from issuance of long-term notes Proceeds from Sale of Intangible Assets Proceeds from the sale of intangible assets Proceeds From Issuance Of Common Stock And Warrants Proceeds from issuance of common stock and warrants, net of issuance costs of $780 Proceeds from issuance of common stock and warrants, net of offering costs. Repayments of Short-term Debt Payment of short-term debt Payment of short-term debt Net Cash Provided by (Used in) Financing Activities, Continuing Operations Net cash provided by financing activities Cash and Cash Equivalents, Period Increase (Decrease) Net decrease in cash and cash equivalents Supplemental Cash Flow Information [Abstract] Supplementary disclosure of cash flow information Interest Paid Interest paid Income Taxes Paid, Net Income tax paid Noncash Investing and Financing Items [Abstract] Non-cash financing and investing transactions Noncash or Part Noncash Acquisition, Fixed Assets Acquired Acquisition of property and equipment through capital lease Discount On Long Term Notes Payable Discount on long term notes payable Discount on long term notes payable in non cash financing and investing activities. Debt Conversion, Converted Instrument, Amount Conversion of convertible notes plus accrued interest into 683 shares of Common Stock Conversion of convertible notes into Common Stock Warrants and recorded a discount to the long-term notes Deferred Compensation Plus Accrued Interest Conversion Amount Conversion of deferred compensation plus accrued interest into 286 shares of Common Stock Deferred compensation plus accrued interest conversion amount. Long Term Unsecured Convertible Promissory Notes For Long Term Unsecured Convertible Promissory Notes Exchange of long-term unsecured convertible promissory notes for long-term unsecured convertible promissory notes Exchange of long-term unsecured convertible promissory notes for long-term unsecured convertible promissory notes. Long Term Unsecured Convertible Promissory Notes For Long Term Secured Convertible Promissory Notes Exchange of long-term unsecured convertible promissory notes for long-term secured convertible promissory notes Exchange of long-term unsecured convertible promissory notes for long-term secured convertible promissory notes. Dividends, Preferred Stock Dividends on Preferred Stock Dividends Debt Instrument, Convertible, Beneficial Conversion Feature Accretion of beneficial conversion feature on issuance of Preferred Stock Debt Instrument Convertible Beneficial Conversion Feature Related To Dividends Accretion of beneficial conversion feature on issuance of Preferred Stock dividends Beneficial Conversion Feature Related to dividends Debt instrument convertible beneficial conversion feature related to dividends. Equity Components [Axis] Equity Component [Domain] Common Stock And Warrants [Member] Common stock and warrants Common stock and warrants. Payments of Stock Issuance Costs Net of offering costs Sale Of Stock Number Of Shares Issued In Notes Conversion Conversion of convertible notes plus accrued interest in common stock, shares Number of shares issued in notes conversion. Sale Of Stock Number Of Shares Issued In Deferred Compensation Conversion Conversion of deferred compensation plus accrued interest in common stock, shares Accretion of beneficial conversion feature on issuance of convertible Preferred Stock. Nature of Business and Summary of Significant Accounting Policies [Abstract] Summary of Significant Accounting Policies Nature of Business, Basis of Presentation and Summary of Significant Accounting Policies [Abstract] Business Description and Accounting Policies [Text Block] Nature of business and summary of significant accounting policies Concentrations [Abstract] Concentration Risk Disclosure [Text Block] Concentrations Intangible Assets [Abstract] Intangible Assets Disclosure [Text Block] Intangible Assets Net Loss Per Share [Abstract] Earnings Per Share [Text Block] Net loss per share Debt [Abstract] Debt [Abstract] Debt Disclosure [Text Block] Debt Equity (Deficit) [Abstract] Stockholders' Equity Note Disclosure [Text Block] Equity (Deficit) Basis of Accounting, Policy [Policy Text Block] Basis of Presentation Going Concern [Policy Text Block] Going Concern Disclosure of accounting policy for going concern. New Accounting Pronouncements, Policy [Policy Text Block] Accounting Changes and Recent Accounting Pronouncements Accounting Changes and Recent Accounting Pronouncements Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Summary of accounts receivable and revenue concentrations Schedule of Finite-Lived Intangible Assets [Table Text Block] Summary of intangible assets Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of diluted earnings per share as the exercise of such options and warrants and the conversion of such preferred shares would be anti-dilutive Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block] Schedule of stock options granted based on fair value assumptions Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block] Summary of stock-based compensation expense related to stock option grants Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Summary of option activity Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block] Summary of significant ranges of outstanding and exercisable options Schedule of Stock Options Roll Forward [Table Text Block] Summary of status of the Company's non-vested shares Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Summary of the warrant activity Schedule Of Stockholders Equity Note Warrants Or Rights Status [Text Block] Summary of warrants outstanding and exercisable Tabular disclosure of warrants outstanding. Nature Of Business And Summary Of Significant Accounting Policies Textual [Abstract] Nature of Business and Summary of Significant Accounting Policies (Textual) Concentration Risk [Table] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Accounts Receivable [Member] Accounts Receivable [Member] Sales Revenue, Services, Net [Member] Total Revenue [Member] Major Customers [Axis] Name of Major Customer [Domain] Customer One [Member] Customer One Customer #1 [Member] Customer Two[Member] Customer Two Customer #2 [Member] Customer Three [Member] Customer Three Customer #3 [Member] Customer Four [Member] Customer Four Customer #4 [Member] Customer Five [Member] Customer Five Customer #5 [Member] Customer Six [Member] Customer #6 [Member] Customer Seven [Member] Customer #7 [Member] Concentration Risk [Line Items] Concentration Risk, Percentage Concentration risk, percentage Total concentration Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Technology-Based Intangible Assets [Member] Technology [Member] Finite-Lived Intangible Assets [Line Items] Amortizable Intangible Assets [Abstract] Amortizable intangible assets Finite-Lived Intangible Assets, Gross Carrying Amount Finite-Lived Intangible Assets, Accumulated Amortization Accumulated Amortization Intangible Assets Textual [Abstract] Intangible Assets (Textual) Amortization of Intangible Assets Amortization of intangible assets costs Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Employee Stock Option [Member] Stock options [Member] Warrants [Member] Warrants [Member] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] EX-101.PRE 11 isgn-20170930_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2017	Nov. 14, 2017
Document and Entity Information [Abstract]
Entity Registrant Name	iSign Solutions Inc.
Entity Central Index Key	0000727634
Amendment Flag	false
Trading Symbol	ISGN
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Sep. 30, 2017
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	Q3
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		5,761,980

XML 13 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Current assets:
Cash and cash equivalents	$ 164	$ 389
Accounts receivable, net of allowance of $0 at September 30, 2017 and $63 at December 31, 2016, respectively	83	137
Prepaid expenses and other current assets	30	56
Total current assets	277	582
Property and equipment, net	12	20
Intangible assets, net	27	269
Other assets	17	17
Total assets	333	888
Current liabilities:
Accounts payable	1,295	1,368
Accrued compensation	200	257
Other accrued liabilities	622	505
Deferred revenue	377	258
Short-term capital lease	4	4
Total current liabilities	2,498	2,392
Long-term debt, net	1,284	707
Deferred revenue long-term	210	315
Long-term capital lease	7	9
Other long-term liabilities	7	13
Total liabilities	4,006	3,436
Commitments and contingencies
Deficit:
Common stock, $0.01 par value; 20,000 shares authorized; 5,762 shares issued and outstanding at September 30, 2017 and December 31, 2016	58	58
Treasury shares, 5 at September 30, 2017 and December 31, 2016	(325)	(325)
Additional paid-in capital	128,983	128,884
Accumulated deficit	(131,839)	(130,615)
Accumulated other comprehensive loss	(14)	(14)
Total iSign stockholders' deficit	(3,137)	(2,012)
Non-controlling interest	(536)	(536)
Total deficit	(3,673)	(2,548)
Total liabilities and deficit	$ 333	$ 888

XML 14 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) shares in Thousands, $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Statement of Financial Position [Abstract]
Accounts receivable, net of allowance	$ 0	$ 63
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	20,000	20,000
Common stock, shares issued	5,762	5,762
Common stock, shares outstanding	5,762	5,762
Treasury Stock, Shares	5	5

XML 15 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Revenue:
Product	$ 65	$ 50	$ 157	$ 273
Maintenance	165	171	498	580
Total revenue	230	221	655	853
Cost of sales:
Product	4	12	11	66
Maintenance	23	77	92	294
Research and development	299	282	884	968
Sales and marketing	28	52	136	381
General and administrative	241	368	920	1,709
Total operating costs and expenses	595	791	2,043	3,418
Loss from operations	(365)	(570)	(1,388)	(2,565)
Other income (expense), net	(5)	1	68	(11)
Gain on sale of intangible asset			239
Interest expense:
Related party	(6)	(10)	(18)	(91)
Other	(23)	(9)	(53)	(107)
Amortization of debt discount:
Related party	(6)	(2)	(20)	(58)
Other	(18)	(15)	(52)	(225)
Gain on derivative liability		156		330
Net loss	(423)	(449)	(1,224)	(2,727)
Accretion of beneficial conversion feature: Preferred Stock:
Related party				(115)
Other				(130)
Preferred stock dividends:
Related party				(646)
Other				(667)
Net loss attributable to common stockholders	$ (423)	$ (449)	$ (1,224)	$ (4,285)
Basic and diluted net loss per common share	$ (0.07)	$ (0.08)	$ (0.21)	$ (1.53)
Weighted average common shares outstanding, basic and diluted	5,762	5,498	5,762	2,794

XML 16 R5.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash flows from operating activities:
Net loss	$ (1,224)	$ (2,727)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	252	276
Debt discount amortization	72	283
Stock-based compensation	99	139
Gain on sale of intangible asset	(239)
Gain on derivative liability		(330)
Changes in operating assets and liabilities:
Accounts receivable	54	(75)
Prepaid expenses and other assets	26	307
Accounts payable	(73)	602
Accrued compensation	(57)	1
Other accrued and long-term liabilities	109	369
Deferred revenue	14	(115)
Net cash used in operating activities	(967)	(1,270)
Cash flows from investing activities:
Acquisition of property and equipment	(2)
Net cash used in investing activities	(2)
Cash flows from financing activities:
Proceeds from issuance of short-term notes payable		100
Proceeds from issuance of long-term notes	505	240
Proceeds from the sale of intangible assets	239
Proceeds from issuance of common stock and warrants, net of issuance costs of $780		424
Payment of short-term debt		(200)
Net cash provided by financing activities	744	564
Net decrease in cash and cash equivalents	(225)	(706)
Cash and cash equivalents at beginning of period	389	846
Cash and cash equivalents at end of period	164	140
Supplementary disclosure of cash flow information
Interest paid	9	40
Income tax paid
Non-cash financing and investing transactions
Acquisition of property and equipment through capital lease		15
Discount on long term notes payable		103
Conversion of convertible notes plus accrued interest into 683 shares of Common Stock		1,188
Conversion of deferred compensation plus accrued interest into 286 shares of Common Stock		498
Exchange of long-term unsecured convertible promissory notes for long-term unsecured convertible promissory notes	200
Exchange of long-term unsecured convertible promissory notes for long-term secured convertible promissory notes	250
Dividends on Preferred Stock		1,313
Accretion of beneficial conversion feature on issuance of Preferred Stock
Accretion of beneficial conversion feature on issuance of Preferred Stock dividends		$ 245

XML 17 R6.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical) shares in Thousands, $ in Thousands	9 Months Ended
	Sep. 30, 2016 USD ($) shares
Conversion of convertible notes plus accrued interest in common stock, shares	683
Conversion of deferred compensation plus accrued interest in common stock, shares	286
Common stock and warrants
Net of offering costs \| $	$ 780

XML 18 R7.htm IDEA: XBRL DOCUMENT

Nature of Business and Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2017

Nature of Business and Summary of Significant Accounting Policies [Abstract]

Nature of business and summary of significant accounting policies

1.	Nature of business and summary of significant accounting policies

Nature of Business

Basis of Presentation

Going Concern

XML 19 R8.htm IDEA: XBRL DOCUMENT

Concentrations

9 Months Ended

Sep. 30, 2017

Concentrations [Abstract]

Concentrations

The following table summarizes accounts receivable and revenue concentrations:

	Accounts Receivable As of September 30,						Total Revenue for the three months ended September 30,						Total Revenue for the nine months ended September 30,
	2017			2016			2017			2016			2017			2016
Customer #1		53	%		13	%		10	%		-			10	%		-
Customer #2		18	%		-			-			-			-			-
Customer #3		-			-			14	%		14	%		14	%		12	%
Customer #4		-			56	%		15	%		16	%		16	%		24	%
Customer #5		-			-			15	%		16	%		16	%		12	%
Customer #6		-			17	%		-			-			-			-
Customer #7		25	%		-			-			-			-			-
Total concentration		96	%		86	%		54	%		46	%		56	%		48	%

XML 20 R9.htm IDEA: XBRL DOCUMENT

Intangible Assets

9 Months Ended

Sep. 30, 2017

Intangible Assets [Abstract]

Intangible Assets

Amortization of intangible asset costs was $81 and $242 for the three and nine-month periods ended September 30, 2017 and $81 and $242 for the three and nine-month periods ended September 30, 2016.

The following table summarizes the intangible assets:

	September 30, 2017							December 31, 2016
	Carrying Amount		Accumulated Amortization			Net Value		Carrying Amount		Accumulated Amortization			Net Value
Amortizable intangible assets
Technology	$	6,745	$	(6,718	)	$	27	$	6,745	$	(6,476	)	$	269

XML 21 R10.htm IDEA: XBRL DOCUMENT

Net Loss Per Share

9 Months Ended

Sep. 30, 2017

Net Loss Per Share [Abstract]

Net loss per share

4.	Net loss per share

The following table lists shares and warrants that were excluded from the calculation of diluted earnings per share as the exercise of such options and warrants would be antidilutive:

	For the Three and Nine Months Ended
	September 30, 2017		September 30, 2016

Stock options		566		71
Warrants		1,878		1,756

XML 22 R11.htm IDEA: XBRL DOCUMENT

Debt

9 Months Ended

Sep. 30, 2017

Debt [Abstract]

Debt

Advances:

Notes payable:

The Company used the funds received from the above financing for working capital and general corporate purposes.

The Company recorded $24 and $72 in debt discount amortization for the three and nine months ended September 30, 2017, respectively, related to the above 2016 debt financings.

XML 23 R12.htm IDEA: XBRL DOCUMENT

Equity (Deficit)

9 Months Ended

Sep. 30, 2017

Equity (Deficit) [Abstract]

Equity (Deficit)

There were no stock options granted, and no stock options exercised during the three and nine months ended September 30, 2016.

The fair value calculations for the stock options granted are based on the following assumptions:

	Nine Months Ended September 30, 2017
Risk free interest rate		1.56	%
Expected life (years)		5.3
Expected volatility		212.15	%
Expected dividends		None

The following table summarizes the allocation of stock-based compensation expense related to stock option grants for the three and nine-month periods ended September 30, 2017 and 2016.

	Three Months Ended September 30,				Nine Months Ended September 30,
	2017		2016		2017		2016
Research and development	$	15	$	12	$	35	$	46
Sales and marketing		-		-		-		15
General and administrative		19		15		39		59
Director options		10		5		25		19
Stock-based compensation expense	$	44	$	32	$	99	$	139

A summary of option activity under the Company’s plans as of September 30, 2017 and 2016 is as follows:

	2017									2016
Options	Shares			Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value		Shares			Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value
Outstanding at January 1,		71		$	45.21			$	-		82		$	45.35			$	-
Granted		502		$	0.50			$	-		-		$	-			$	-
Forfeited or expired		(7	)	$	7.21			$	-		(11	)	$	45.66			$	-
Outstanding at September 30		566		$	6.02		6.09	$	-		71		$	45.30		3.41	$	-
Vested and expected to vest at September 30		520		$	6.04		6.04	$	-		70		$	46.14		3.36	$	-
Exercisable at September 30		106		$	29.05		3.92	$	-		58		$	49.70		2.95	$	-

The following table summarizes significant ranges of outstanding and exercisable options as of September 30, 2017:

	Options Outstanding						Options Exercisable
Range of Exercise Prices	Number Outstanding		Weighted Average Remaining Contractual Life (in years)		Weighted Average Exercise Price Per Share		Number Outstanding		Weighted Average Exercise Price Per Share
$0.01 – $25.00		498		6.60	$	0.56		42	$	1.02
$25.01 - $625.00		68		2.33	$	46.17		64	$	47.25
Total		566		6.09	$	6.02		106	$	29.05

The following table summarizes the Company’s non-vested option shares as of September 30, 2017:

Non-vested Option Shares	Shares			Weighted Average Grant-Date Fair Value
Non-vested at January 1, 2017		11		$	23.01
Granted		502		$	0.50
Forfeited		(6	)	$	0.75
Vested		(47	)	$	0.99
Non-vested at September 30, 2017		460		$	0.76

Warrants

A summary of the warrant activity for the nine months ended September 30 is as follows:

	September 30, 2017					September 30, 2016
	Shares			Weighted Average Exercise Price Per Share		Shares		Weighted Average Exercise Price Per Share
Outstanding at beginning of period		1,882		$	2.52		205	$	35.51
Issued		-		$	-		1,551	$	2.18
Expired		(4	)	$	34.38		-	$	-
Outstanding at end of period		1,878		$	1.53		1,756	$	5.27
Exercisable at end of period		1,878		$	1.53		1,756	$	5.27

A summary of the status of the warrants outstanding and exercisable as of September 30, 2017 is as follows:

Number of shares exercisable under Warrants		Weighted Average Remaining Life Years		Weighted Average Exercise Price per share

	50		0.01	$	0.42
	277		0.42	$	0.24
	1,551		3.04	$	1.80
	1,878		2.57	$	1.53

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74567-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(d))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

+ Details

XML 24 R13.htm IDEA: XBRL DOCUMENT

Nature of Business and Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2017
Nature of Business and Summary of Significant Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The financial information contained herein should be read in conjunction with the Company's consolidated audited financial statements and notes thereto included in its Annual Report on Form 10-K for the year ended December 31, 2016. The accompanying unaudited condensed consolidated financial statements of the Company have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America (“GAAP”) for complete consolidated financial statements. In the opinion of management, the unaudited condensed consolidated financial statements included in this quarterly report reflect all adjustments (consisting only of normal recurring adjustments) that the Company considers necessary for a fair presentation of its financial position at the dates presented and the Company’s results of operations and cash flows for the periods presented. The Company’s interim results are not necessarily indicative of the results to be expected for the entire year.
Going Concern	Going Concern The accompanying unaudited condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has incurred significant cumulative losses since its inception and, at September 30, 2017, the Company’s accumulated deficit was $131,839. The Company has primarily met its working capital needs through the sale of debt and equity securities. As of September 30, 2017, the Company’s cash balance was $164. These factors raise substantial doubt about the Company’s ability to continue as a going concern. There can be no assurance that the Company will be successful in securing adequate capital resources to fund planned operations or that any additional funds will be available to the Company when needed, or if available, will be available on favorable terms or in amounts required by the Company. If the Company is unable to obtain adequate capital resources to fund operations, it may be required to delay, scale back or eliminate some or all of its operations, which may have a material adverse effect on the Company's business, results of operations and ability to operate as a going concern. The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Accounting Changes and Recent Accounting Pronouncements	Accounting Changes and Recent Accounting Pronouncements In May 2017, the Financial Accounting Standards Board (“FASB”) issued ASU 2017-09, Compensation (Subtopic 718-20): Stock Compensation - Scope of Modification Accounting. ASU 2017-09 provides guidance on determining which changes to the terms and conditions of share-based payment awards require an entity to apply modification accounting under Topic 718. The guidance is effective for annual periods after December 15, 2017. Implementation of ASU 2017-09 is not expected to have a material impact on the Company’s financial position, results of operations and cash flows. In July 2017, the FASB issued ASU 2017-11, Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Non-controlling Interests with a Scope Exception. ASU 2017-11 addresses the narrow issues identified as a result of the complexity associated with applying generally accepted accounting principles (GAAP) for certain financial instruments with characteristics of liabilities and equity in two parts, (1) Addressing financial instruments with down round features, and (2) which relates to non-public entities. For public business entities, the amendments in Part I of this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities. ASU 2017-12 has been issued with the objective of improving the financial reporting of hedging relationships to better portray the economic results of an entity’s risk management activities in its financial statements. In addition to that main objective, the amendments in this Update make certain targeted improvements to simplify the application of the hedge accounting guidance in current GAAP based on the feedback received from preparers, auditors, users, and other stakeholders. For public business entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. In September 2017, the FASB issued ASU 2017-13, Revenue Recognition (Topic 605), Revenue from Contracts with Customers (Topic 606), Leases (Topic 840), and Leases (Topic 842). ASU 2017-13 adds SEC paragraphs pursuant to an SEC Staff Announcement made at the July 20, 2017 Emerging Issues Task Force (EITF) meeting. Implementation of the above ASU’s issued in 2017 are not expected to have a material impact on the Company’s financial position, results of operations and cash flows.

XML 25 R14.htm IDEA: XBRL DOCUMENT

Concentrations (Tables)

9 Months Ended

Sep. 30, 2017

Concentrations [Abstract]

Summary of accounts receivable and revenue concentrations

	Accounts Receivable As of September 30,						Total Revenue for the three months ended September 30,						Total Revenue for the nine months ended September 30,
	2017			2016			2017			2016			2017			2016
Customer #1		53	%		13	%		10	%		-			10	%		-
Customer #2		18	%		-			-			-			-			-
Customer #3		-			-			14	%		14	%		14	%		12	%
Customer #4		-			56	%		15	%		16	%		16	%		24	%
Customer #5		-			-			15	%		16	%		16	%		12	%
Customer #6		-			17	%		-			-			-			-
Customer #7		25	%		-			-			-			-			-
Total concentration		96	%		86	%		54	%		46	%		56	%		48	%

XML 26 R15.htm IDEA: XBRL DOCUMENT

Intangible Assets (Tables)

9 Months Ended

Sep. 30, 2017

Intangible Assets [Abstract]

Summary of intangible assets

	September 30, 2017							December 31, 2016
	Carrying Amount		Accumulated Amortization			Net Value		Carrying Amount		Accumulated Amortization			Net Value
Amortizable intangible assets
Technology	$	6,745	$	(6,718	)	$	27	$	6,745	$	(6,476	)	$	269

XML 27 R16.htm IDEA: XBRL DOCUMENT

Net Loss Per Share (Tables)

9 Months Ended

Sep. 30, 2017

Net Loss Per Share [Abstract]

Schedule of diluted earnings per share as the exercise of such options and warrants and the conversion of such preferred shares would be anti-dilutive

	For the Three and Nine Months Ended
	September 30, 2017		September 30, 2016

Stock options		566		71
Warrants		1,878		1,756

XML 28 R17.htm IDEA: XBRL DOCUMENT

Equity (Deficit) (Tables)

9 Months Ended

Sep. 30, 2017

Equity (Deficit) [Abstract]

Schedule of stock options granted based on fair value assumptions

	Nine Months Ended September 30, 2017
Risk free interest rate		1.56	%
Expected life (years)		5.3
Expected volatility		212.15	%
Expected dividends		None

Summary of stock-based compensation expense related to stock option grants

	Three Months Ended September 30,				Nine Months Ended September 30,
	2017		2016		2017		2016
Research and development	$	15	$	12	$	35	$	46
Sales and marketing		-		-		-		15
General and administrative		19		15		39		59
Director options		10		5		25		19
Stock-based compensation expense	$	44	$	32	$	99	$	139

Summary of option activity

	2017									2016
Options	Shares			Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value		Shares			Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value
Outstanding at January 1,		71		$	45.21			$	-		82		$	45.35			$	-
Granted		502		$	0.50			$	-		-		$	-			$	-
Forfeited or expired		(7	)	$	7.21			$	-		(11	)	$	45.66			$	-
Outstanding at September 30		566		$	6.02		6.09	$	-		71		$	45.30		3.41	$	-
Vested and expected to vest at September 30		520		$	6.04		6.04	$	-		70		$	46.14		3.36	$	-
Exercisable at September 30		106		$	29.05		3.92	$	-		58		$	49.70		2.95	$	-

Summary of significant ranges of outstanding and exercisable options

	Options Outstanding						Options Exercisable
Range of Exercise Prices	Number Outstanding		Weighted Average Remaining Contractual Life (in years)		Weighted Average Exercise Price Per Share		Number Outstanding		Weighted Average Exercise Price Per Share
$0.01 – $25.00		498		6.60	$	0.56		42	$	1.02
$25.01 – $625.00		68		2.33	$	46.17		64	$	47.25
Total		566		6.09	$	6.02		106	$	29.05

Summary of status of the Company's non-vested shares

Non-vested Option Shares	Shares			Weighted Average Grant-Date Fair Value
Non-vested at January 1, 2017		11		$	23.01
Granted		502		$	0.50
Forfeited		(6	)	$	0.75
Vested		(47	)	$	0.99
Non-vested at September 30, 2017		460		$	0.76

Summary of the warrant activity

	September 30, 2017					September 30, 2016
	Shares			Weighted Average Exercise Price Per Share		Shares		Weighted Average Exercise Price Per Share
Outstanding at beginning of period		1,882		$	2.52		205	$	35.51
Issued		-		$	-		1,551	$	2.18
Expired		(4	)	$	34.38		-	$	-
Outstanding at end of period		1,878		$	1.53		1,756	$	5.27
Exercisable at end of period		1,878		$	1.53		1,756	$	5.27

Summary of warrants outstanding and exercisable

Number of shares exercisable under Warrants		Weighted Average Remaining Life Years		Weighted Average Exercise Price per share

	50		0.01	$	0.42
	277		0.42	$	0.24
	1,551		3.04	$	1.80
	1,878		2.57	$	1.53

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details

XML 29 R18.htm IDEA: XBRL DOCUMENT

Nature of Business and Summary of Significant Accounting Policies (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016	Sep. 30, 2016	Dec. 31, 2015
Nature of Business and Summary of Significant Accounting Policies (Textual)
Accumulated deficit	$ (131,839)	$ (130,615)
Cash balance	$ 164	$ 389	$ 140	$ 846

XML 30 R19.htm IDEA: XBRL DOCUMENT

Concentrations (Details)	3 Months Ended		9 Months Ended
Concentrations (Details)	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Accounts Receivable [Member]
Concentration Risk [Line Items]
Total concentration			96.00%	86.00%
Accounts Receivable [Member] \| Customer #1 [Member]
Concentration Risk [Line Items]
Total concentration			53.00%	13.00%
Accounts Receivable [Member] \| Customer #2 [Member]
Concentration Risk [Line Items]
Total concentration			18.00%
Accounts Receivable [Member] \| Customer #3 [Member]
Concentration Risk [Line Items]
Total concentration
Accounts Receivable [Member] \| Customer #4 [Member]
Concentration Risk [Line Items]
Total concentration				56.00%
Accounts Receivable [Member] \| Customer #5 [Member]
Concentration Risk [Line Items]
Total concentration
Accounts Receivable [Member] \| Customer #6 [Member]
Concentration Risk [Line Items]
Total concentration				17.00%
Accounts Receivable [Member] \| Customer #7 [Member]
Concentration Risk [Line Items]
Total concentration			25.00%
Total Revenue [Member]
Concentration Risk [Line Items]
Total concentration	54.00%	46.00%	56.00%	48.00%
Total Revenue [Member] \| Customer #1 [Member]
Concentration Risk [Line Items]
Total concentration	10.00%		10.00%
Total Revenue [Member] \| Customer #2 [Member]
Concentration Risk [Line Items]
Total concentration
Total Revenue [Member] \| Customer #3 [Member]
Concentration Risk [Line Items]
Total concentration	14.00%	14.00%	14.00%	12.00%
Total Revenue [Member] \| Customer #4 [Member]
Concentration Risk [Line Items]
Total concentration	15.00%	16.00%	16.00%	24.00%
Total Revenue [Member] \| Customer #5 [Member]
Concentration Risk [Line Items]
Total concentration	15.00%	16.00%	16.00%	12.00%
Total Revenue [Member] \| Customer #6 [Member]
Concentration Risk [Line Items]
Total concentration
Total Revenue [Member] \| Customer #7 [Member]
Concentration Risk [Line Items]
Total concentration

XML 31 R20.htm IDEA: XBRL DOCUMENT

Intangible Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Amortizable intangible assets
Net Value	$ 27	$ 269
Technology [Member]
Amortizable intangible assets
Carrying Amount	6,745	6,745
Accumulated Amortization	(6,718)	(6,476)
Net Value	$ 27	$ 269

XML 32 R21.htm IDEA: XBRL DOCUMENT

Intangible Assets (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Intangible Assets (Textual)
Amortization of intangible assets costs	$ 81	$ 81	$ 242	$ 242

XML 33 R22.htm IDEA: XBRL DOCUMENT

Net Loss Per Share (Details) - shares shares in Thousands	9 Months Ended
Net Loss Per Share (Details) - shares shares in Thousands	Sep. 30, 2017	Sep. 30, 2016
Stock options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-diluted earnings per share of options and warrants shares	566	71
Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-diluted earnings per share of options and warrants shares	1,878	1,756

XML 34 R23.htm IDEA: XBRL DOCUMENT

Debt (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended					3 Months Ended	9 Months Ended
	May 31, 2017	Feb. 28, 2017	Nov. 30, 2016	Oct. 31, 2016	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2017	Sep. 30, 2016
Debt (Textual)
Warrants and recorded a discount to the long-term notes								$ 1,188
Proceeds from issuance of long-term notes							505	$ 240
Debt [Member]
Debt (Textual)
Aggregating amount of debt		$ 120
Advance fees						$ 6	6
Description of advance fee		The Company would repay the advance to the lenders on a pro rata basis together with a 5% advance fee.
Unsecured convertible promissory notes [Member] \| Investors and Affiliates [Member]
Debt (Textual)
Warrants issued to purchase of common stock			277
Proceeds from issuance of long-term notes	$ 505		$ 700
Description of replacement notes	Should the secured notes remain outstanding following the maturity date an additional 30% of the note's principal amount shall become due and payable.
Unsecured convertible promissory notes received	$ 250
Demand promissory notes [Member] \| Investors and Affiliates [Member]
Debt (Textual)
Exchange of demand notes for long-term unsecured convertible notes				$ 200	$ 200
Notes Payable [Member]
Debt (Textual)
Conversion price	$ 0.50		$ 1.30
Proceeds of equity financing	$ 1,000		$ 1,000
Interest rate	10.00%		6.00%
Due date	Dec. 31, 2018		Dec. 31, 2018
Debt discount amortization						$ 24	$ 72
Notes Payable [Member] \| Minimum [Member]
Debt (Textual)
Warrants and recorded a discount to the long-term notes			$ 204
Notes Payable [Member] \| Maximum [Member]
Debt (Textual)
Warrants and recorded a discount to the long-term notes			$ 277

XML 35 R24.htm IDEA: XBRL DOCUMENT

Equity (Deficit) (Details)	9 Months Ended
Equity (Deficit) (Details)	Sep. 30, 2017
Schedule of stock options granted based on fair value assumtions
Risk free interest rate	1.56%
Expected life (years)	5 years 3 months 19 days
Expected volatility	212.15%
Expected dividends

XML 36 R25.htm IDEA: XBRL DOCUMENT

Equity (Deficit) (Details1) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Equity (Deficit) (Details1) - USD ($) $ in Thousands	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	$ 44	$ 32	$ 99	$ 139
Research and development [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	15	12	35	46
Sales and marketing [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense				15
General and administrative [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	19	15	39	59
Director options [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	$ 10	$ 5	$ 25	$ 19

XML 37 R26.htm IDEA: XBRL DOCUMENT

Equity (Deficit) (Details 2) - USD ($) shares in Thousands	9 Months Ended
Equity (Deficit) (Details 2) - USD ($) shares in Thousands	Sep. 30, 2017	Sep. 30, 2016
Equity (Deficit) [Abstract]
Options Shares, Outstanding, Beginning balance	71	82
Options Shares, Granted	502
Options Shares, Forfeited or expired	(7)	(11)
Options Shares, Outstanding, Ending balance	566	71
Options Shares, Vested and expected to vest	520	70
Options Shares, Exercisable	106	58
Weighted Average Exercise Price Per Share, Outstanding, Beginning balance	$ 45.21	$ 45.35
Weighted Average Exercise Price Per Share, Granted	0.50
Weighted Average Exercise Price Per Share, Forfeited or expired	7.21	45.66
Weighted Average Exercise Price Per Share, Outstanding, Ending balance	6.02	45.30
Weighted Average Exercise Price Per Share, Vested and expected to vest	6.04	46.14
Weighted Average Exercise Price Per Share, Exercisable	$ 29.05	$ 49.70
Weighted Average Remaining Contractual Life, Outstanding	6 years 1 month 2 days	3 years 4 months 28 days
Weighted Average Remaining Contractual Life (Years), Vested and expected to vest	6 years 15 days	3 years 4 months 9 days
Weighted Average Remaining Contractual Life (Years), Exercisable	3 years 11 months 1 day	2 years 11 months 12 days
Aggregate Intrinsic Value, Outstanding, Beginning balance
Aggregate Intrinsic Value, Granted
Aggregate Intrinsic Value, Forfeited or expired
Aggregate Intrinsic Value, Outstanding, Ending balance
Aggregate Intrinsic Value, Vested and expected to vest
Aggregate Intrinsic Value, Exercisable

XML 38 R27.htm IDEA: XBRL DOCUMENT

Equity (Deficit) (Details 3)	9 Months Ended
Equity (Deficit) (Details 3)	Sep. 30, 2017 $ / shares shares
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Number Outstanding \| shares	566
Options Outstanding, Weighted Average Remaining Contractual Term (Years)	6 years 1 month 2 days
Options Outstanding, Weighted Average Exercise Price	$ 6.02
Options Exercisable, Number Outstanding \| shares	106
Options Exercisable, Weighted Average Exercise Price Per Share	$ 29.05
$0.01 - $25.00 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices, Lower Range Limit	0.01
Range of Exercise Prices, Upper Range Limit	$ 25.00
Options Outstanding, Number Outstanding \| shares	498
Options Outstanding, Weighted Average Remaining Contractual Term (Years)	6 years 7 months 6 days
Options Outstanding, Weighted Average Exercise Price	$ 0.56
Options Exercisable, Number Outstanding \| shares	42
Options Exercisable, Weighted Average Exercise Price Per Share	$ 1.02
$25.01 - 625.00 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices, Lower Range Limit	25.01
Range of Exercise Prices, Upper Range Limit	$ 625.00
Options Outstanding, Number Outstanding \| shares	68
Options Outstanding, Weighted Average Remaining Contractual Term (Years)	2 years 3 months 29 days
Options Outstanding, Weighted Average Exercise Price	$ 46.17
Options Exercisable, Number Outstanding \| shares	64
Options Exercisable, Weighted Average Exercise Price Per Share	$ 47.25

XML 39 R28.htm IDEA: XBRL DOCUMENT

Equity (Deficit) (Details 4) shares in Thousands	9 Months Ended
Equity (Deficit) (Details 4) shares in Thousands	Sep. 30, 2017 $ / shares shares
Equity Instruments, Options, Nonvested Shares Roll-Forward
Non-vested, Shares, Beginning balance \| shares	11
Non-vested, Shares, Granted \| shares	502
Non-vested, Shares, Forfeited \| shares	(6)
Non-vested, Shares, Vested \| shares	(47)
Non-vested, Shares, Ending balance \| shares	460
Weighted Average Grant-Date Fair Value, Non-vested, Beginning balance \| $ / shares	$ 23.01
Weighted Average Grant-Date Fair Value, Granted \| $ / shares	0.50
Weighted Average Grant-Date Fair Value, Forfeited \| $ / shares	0.75
Weighted Average Grant-Date Fair Value, Vested \| $ / shares	0.99
Weighted Average Grant-Date Fair Value, Non-vested, Ending balance \| $ / shares	$ 0.76

XML 40 R29.htm IDEA: XBRL DOCUMENT

Equity (Deficit) (Details 5) - Warrants [Member] - $ / shares shares in Thousands	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of Shares, Outstanding at beginning of period	1,882	205
Number of Shares, Issued		1,551
Number of Shares, Expired	(4)
Number of Shares, Outstanding at end of period	1,878	1,756
Number of Shares, Exercisable at end of period	1,878	1,756
Weighted Average Exercise Price Per Share, Outstanding at beginning of period	$ 2.52	$ 35.51
Weighted Average Exercise Price Per Share, Issued		2.18
Weighted Average Exercise Price Per Share, Expired	34.38
Weighted Average Exercise Price Per Share, Outstanding at end of period	1.53	5.27
Weighted Average Exercise Price Per Share, Exercisable at end of period	$ 1.53	$ 5.27

XML 41 R30.htm IDEA: XBRL DOCUMENT

Equity (Deficit) (Details 6) - Warrants outstanding and exercisable [Member] shares in Thousands	9 Months Ended
	Sep. 30, 2017 $ / shares shares
50 [Member]
Class of Warrant or Right [Line Items]
Number of Warrants \| shares	50
Weighted Average Remaining Life Years	4 days
Weighted Average Exercise Price per share \| $ / shares	$ 0.42
277 [Member]
Class of Warrant or Right [Line Items]
Number of Warrants \| shares	277
Weighted Average Remaining Life Years	5 months 1 day
Weighted Average Exercise Price per share \| $ / shares	$ 0.24
1,551 [Member]
Class of Warrant or Right [Line Items]
Number of Warrants \| shares	1,551
Weighted Average Remaining Life Years	3 years 15 days
Weighted Average Exercise Price per share \| $ / shares	$ 1.80
1,878 [Member]
Class of Warrant or Right [Line Items]
Number of Warrants \| shares	1,878
Weighted Average Remaining Life Years	2 years 6 months 25 days
Weighted Average Exercise Price per share \| $ / shares	$ 1.53

XML 42 R31.htm IDEA: XBRL DOCUMENT

Equity (Deficit) (Details Textual) $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended
	Sep. 30, 2017 USD ($) $ / shares shares
Equity (Deficit) (Textual)
Stock options granted \| shares	502
Weighted average exercise price per share \| $ / shares	$ 0.50
Unrecognized compensation expense \| $	$ 101
Unrecognized compensation expense, expected period	2 years 1 month 6 days

EXCEL 43 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 44 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 45 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 47 FilingSummary.xml IDEA: XBRL DOCUMENT 3.8.0.1 html 113 193 1 false 32 0 false 4 false false R1.htm 001 - Document - Document and Entity Information Sheet http://isignnow.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 002 - Statement - Condensed Consolidated Balance Sheets Sheet http://isignnow.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://isignnow.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://isignnow.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://isignnow.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical) Sheet http://isignnow.com/role/CondensedConsolidatedStatementsOfCashFlowsUnauditedParenthetical Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical) Statements 6 false false R7.htm 007 - Disclosure - Nature of Business and Summary of Significant Accounting Policies Sheet http://isignnow.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPolicies Nature of Business and Summary of Significant Accounting Policies Notes 7 false false R8.htm 008 - Disclosure - Concentrations Sheet http://isignnow.com/role/Concentrations Concentrations Notes 8 false false R9.htm 009 - Disclosure - Intangible Assets Sheet http://isignnow.com/role/IntangibleAssets Intangible Assets Notes 9 false false R10.htm 010 - Disclosure - Net Loss Per Share Sheet http://isignnow.com/role/NetLossPerShare Net Loss Per Share Notes 10 false false R11.htm 011 - Disclosure - Debt Sheet http://isignnow.com/role/Debt Debt Notes 11 false false R12.htm 012 - Disclosure - Equity (Deficit) Sheet http://isignnow.com/role/EquityDeficit Equity (Deficit) Notes 12 false false R13.htm 013 - Disclosure - Nature of Business and Summary of Significant Accounting Policies (Policies) Sheet http://isignnow.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies Nature of Business and Summary of Significant Accounting Policies (Policies) Policies http://isignnow.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPolicies 13 false false R14.htm 014 - Disclosure - Concentrations (Tables) Sheet http://isignnow.com/role/ConcentrationsTables Concentrations (Tables) Tables http://isignnow.com/role/Concentrations 14 false false R15.htm 015 - Disclosure - Intangible Assets (Tables) Sheet http://isignnow.com/role/IntangibleAssetsTables Intangible Assets (Tables) Tables http://isignnow.com/role/IntangibleAssets 15 false false R16.htm 016 - Disclosure - Net Loss Per Share (Tables) Sheet http://isignnow.com/role/NetLossPerShareTables Net Loss Per Share (Tables) Tables http://isignnow.com/role/NetLossPerShare 16 false false R17.htm 017 - Disclosure - Equity (Deficit) (Tables) Sheet http://isignnow.com/role/EquityDeficitTables Equity (Deficit) (Tables) Tables http://isignnow.com/role/EquityDeficit 17 false false R18.htm 018 - Disclosure - Nature of Business and Summary of Significant Accounting Policies (Details) Sheet http://isignnow.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetails Nature of Business and Summary of Significant Accounting Policies (Details) Details http://isignnow.com/role/NatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies 18 false false R19.htm 019 - Disclosure - Concentrations (Details) Sheet http://isignnow.com/role/ConcentrationsDetails Concentrations (Details) Details http://isignnow.com/role/ConcentrationsTables 19 false false R20.htm 020 - Disclosure - Intangible Assets (Details) Sheet http://isignnow.com/role/IntangibleAssetsDetails Intangible Assets (Details) Details http://isignnow.com/role/IntangibleAssetsTables 20 false false R21.htm 021 - Disclosure - Intangible Assets (Details Textual) Sheet http://isignnow.com/role/IntangibleAssetsDetailsTextual Intangible Assets (Details Textual) Details http://isignnow.com/role/IntangibleAssetsTables 21 false false R22.htm 022 - Disclosure - Net Loss Per Share (Details) Sheet http://isignnow.com/role/NetLossPerShareDetails Net Loss Per Share (Details) Details http://isignnow.com/role/NetLossPerShareTables 22 false false R23.htm 023 - Disclosure - Debt (Details) Sheet http://isignnow.com/role/DebtDetails Debt (Details) Details http://isignnow.com/role/Debt 23 false false R24.htm 024 - Disclosure - Equity (Deficit) (Details) Sheet http://isignnow.com/role/EquityDeficitDetails Equity (Deficit) (Details) Details http://isignnow.com/role/EquityDeficitTables 24 false false R25.htm 025 - Disclosure - Equity (Deficit) (Details1) Sheet http://isignnow.com/role/EquityDeficitDetails1 Equity (Deficit) (Details1) Details http://isignnow.com/role/EquityDeficitTables 25 false false R26.htm 026 - Disclosure - Equity (Deficit) (Details 2) Sheet http://isignnow.com/role/EquityDeficitDetails2 Equity (Deficit) (Details 2) Details http://isignnow.com/role/EquityDeficitTables 26 false false R27.htm 027 - Disclosure - Equity (Deficit) (Details 3) Sheet http://isignnow.com/role/EquityDeficitDetails3 Equity (Deficit) (Details 3) Details http://isignnow.com/role/EquityDeficitTables 27 false false R28.htm 028 - Disclosure - Equity (Deficit) (Details 4) Sheet http://isignnow.com/role/EquityDeficitDetails4 Equity (Deficit) (Details 4) Details http://isignnow.com/role/EquityDeficitTables 28 false false R29.htm 029 - Disclosure - Equity (Deficit) (Details 5) Sheet http://isignnow.com/role/EquityDeficitDetails5 Equity (Deficit) (Details 5) Details http://isignnow.com/role/EquityDeficitTables 29 false false R30.htm 030 - Disclosure - Equity (Deficit) (Details 6) Sheet http://isignnow.com/role/EquityDeficitDetails6 Equity (Deficit) (Details 6) Details http://isignnow.com/role/EquityDeficitTables 30 false false R31.htm 031 - Disclosure - Equity (Deficit) (Details Textual) Sheet http://isignnow.com/role/EquityDeficitDetailsTextual Equity (Deficit) (Details Textual) Details http://isignnow.com/role/EquityDeficitTables 31 false false All Reports Book All Reports isgn-20170930.xml isgn-20170930.xsd isgn-20170930_cal.xml isgn-20170930_def.xml isgn-20170930_lab.xml isgn-20170930_pre.xml http://xbrl.sec.gov/dei/2014-01-31 http://fasb.org/us-gaap/2016-01-31 true true ZIP 49 0001213900-17-012034-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-17-012034-xbrl.zip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